55 results on '"Yong Shi"'
Search Results
2. Erratum for Vanderheiden et al., 'CCR2 Signaling Restricts SARS-CoV-2 Infection'
- Author
-
Abigail Vanderheiden, Jeronay Thomas, Allison L. Soung, Meredith E. Davis-Gardner, Katharine Floyd, Fengzhi Jin, David A. Cowan, Kathryn Pellegrini, Adrian Creanga, Amarendra Pegu, Alexandrine Derrien-Colemyn, Pei-Yong Shi, Arash Grakoui, Robyn S. Klein, Steven E. Bosinger, Jacob E. Kohlmeier, Vineet D. Menachery, and Mehul S. Suthar
- Subjects
Virology ,Microbiology - Published
- 2022
3. JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis
- Author
-
Juhee Son, Shimeng Huang, Qiru Zeng, Traci L. Bricker, James Brett Case, Jinzhu Zhou, Ruochen Zang, Zhuoming Liu, Xinjian Chang, Tamarand L. Darling, Jian Xu, Houda H. Harastani, Lu Chen, Maria Florencia Gomez Castro, Yongxiang Zhao, Hinissan P. Kohio, Gaopeng Hou, Baochao Fan, Beibei Niu, Rongli Guo, Paul W. Rothlauf, Adam L. Bailey, Xin Wang, Pei-Yong Shi, Elisabeth D. Martinez, Steven L. Brody, Sean P. J. Whelan, Michael S. Diamond, Adrianus C. M. Boon, Bin Li, and Siyuan Ding
- Subjects
SARS-CoV-2 ,viruses ,coronavirus ,virus diseases ,RNA ,Biology ,medicine.disease_cause ,Microbiology ,Virology ,Virus ,In vitro ,law.invention ,chemistry.chemical_compound ,chemistry ,law ,In vivo ,JIB-04 ,antiviral agents ,Recombinant DNA ,medicine ,Vero cell ,DNA ,Coronavirus ,Research Article - Abstract
Pathogenic coronaviruses represent a major threat to global public health. Here, using a recombinant reporter virus-based compound screening approach, we identified several small-molecule inhibitors that potently block the replication of the newly emerged severe acute respiratory syndrome virus 2 (SARS-CoV-2). Among them, JIB-04 inhibited SARS-CoV-2 replication in Vero E6 cells with an EC50 of 695 nM, with a specificity index of greater than 1,000. JIB-04 showed in vitro antiviral activity in multiple cell types against several DNA and RNA viruses, including porcine coronavirus transmissible gastroenteritis virus. In an in vivo porcine model of coronavirus infection, administration of JIB-04 reduced virus infection and associated tissue pathology, which resulted in improved weight gain and survival. These results highlight the potential utility of JIB-04 as an antiviral agent against SARS-CoV-2 and other viral pathogens.
- Published
- 2022
4. CCR2 Signaling Restricts SARS-CoV-2 Infection
- Author
-
Steven E. Bosinger, Fengzhi Jin, Pei Yong Shi, Jacob E. Kohlmeier, Jeronay Thomas, Vineet D. Menachery, Abigail Vanderheiden, Robyn S. Klein, David A Cowan, Kathryn L. Pellegrini, Meredith E. Davis-Gardner, Arash Grakoui, Allison Soung, Katharine Floyd, and Mehul S. Suthar
- Subjects
Receptors, CCR2 ,medicine.medical_treatment ,viruses ,mouse model ,Pneumonia, Viral ,Inflammation ,Biology ,Virus Replication ,Microbiology ,Proinflammatory cytokine ,Mice ,Virology ,medicine ,Animals ,Lung ,innate immunity ,Innate immune system ,SARS-CoV-2 ,Respiratory disease ,lung inflammation ,COVID-19 ,Viral Load ,respiratory system ,medicine.disease ,Immunity, Innate ,QR1-502 ,respiratory tract diseases ,Mice, Inbred C57BL ,Disease Models, Animal ,Cytokine ,medicine.anatomical_structure ,Immunology ,Cytokines ,Female ,medicine.symptom ,monocytes ,Viral load ,Respiratory tract ,Signal Transduction ,Research Article - Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a historic pandemic of respiratory disease (coronavirus disease 2019 [COVID-19]), and current evidence suggests that severe disease is associated with dysregulated immunity within the respiratory tract. However, the innate immune mechanisms that mediate protection during COVID-19 are not well defined. Here, we characterize a mouse model of SARS-CoV-2 infection and find that early CCR2 signaling restricts the viral burden in the lung. We find that a recently developed mouse-adapted SARS-CoV-2 (MA-SARS-CoV-2) strain as well as the emerging B.1.351 variant trigger an inflammatory response in the lung characterized by the expression of proinflammatory cytokines and interferon-stimulated genes. Using intravital antibody labeling, we demonstrate that MA-SARS-CoV-2 infection leads to increases in circulating monocytes and an influx of CD45+ cells into the lung parenchyma that is dominated by monocyte-derived cells. Single-cell RNA sequencing (scRNA-Seq) analysis of lung homogenates identified a hyperinflammatory monocyte profile. We utilize this model to demonstrate that mechanistically, CCR2 signaling promotes the infiltration of classical monocytes into the lung and the expansion of monocyte-derived cells. Parenchymal monocyte-derived cells appear to play a protective role against MA-SARS-CoV-2, as mice lacking CCR2 showed higher viral loads in the lungs, increased lung viral dissemination, and elevated inflammatory cytokine responses. These studies have identified a potential CCR2-monocyte axis that is critical for promoting viral control and restricting inflammation within the respiratory tract during SARS-CoV-2 infection. IMPORTANCE SARS-CoV-2 has caused a historic pandemic of respiratory disease (COVID-19), and current evidence suggests that severe disease is associated with dysregulated immunity within the respiratory tract. However, the innate immune mechanisms that mediate protection during COVID-19 are not well defined. Here, we characterize a mouse model of SARS-CoV-2 infection and find that early CCR2-dependent infiltration of monocytes restricts the viral burden in the lung. We find that SARS-CoV-2 triggers an inflammatory response in the lung characterized by the expression of proinflammatory cytokines and interferon-stimulated genes. Using RNA sequencing and flow cytometry approaches, we demonstrate that SARS-CoV-2 infection leads to increases in circulating monocytes and an influx of CD45+ cells into the lung parenchyma that is dominated by monocyte-derived cells. Mechanistically, CCR2 signaling promoted the infiltration of classical monocytes into the lung and the expansion of monocyte-derived cells. Parenchymal monocyte-derived cells appear to play a protective role against MA-SARS-CoV-2, as mice lacking CCR2 showed higher viral loads in the lungs, increased lung viral dissemination, and elevated inflammatory cytokine responses. These studies have identified that the CCR2 pathway is critical for promoting viral control and restricting inflammation within the respiratory tract during SARS-CoV-2 infection.
- Published
- 2021
5. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies
- Author
-
Cheah Chen Seh, Chong Wai Liew, Pei Yong Shi, Gang Wang, Christian G. Noble, Timothy E. Benson, Tingjin Sherryl Soh, Thomas M. Smith, Fumiaki Yokokawa, Julien Lescar, Rishi Arora, Kimberley Yue, Siew Pheng Lim, Yen Liang Chen, Dorcas Adobea Otoo, Shahul Nilar, School of Biological Sciences, and NTU Institute of Structural Biology
- Subjects
Models, Molecular ,viruses ,Hepatitis C virus ,Immunology ,RNA-dependent RNA polymerase ,Viral Nonstructural Proteins ,Biology ,Dengue virus ,Crystallography, X-Ray ,Virus Replication ,medicine.disease_cause ,Antiviral Agents ,Microbiology ,Dengue ,chemistry.chemical_compound ,Sequence Analysis, Protein ,Virology ,RNA polymerase ,Vaccines and Antiviral Agents ,medicine ,Humans ,Polymerase ,Binding Sites ,Flaviviruses ,Biological sciences [Science] ,virus diseases ,RNA ,Dengue Virus ,RNA-Dependent RNA Polymerase ,HIV Reverse Transcriptase ,Reverse transcriptase ,High-Throughput Screening Assays ,Viral replication ,chemistry ,Insect Science ,biology.protein ,Replicon ,Sequence Alignment ,Allosteric Site - Abstract
Dengue virus (DENV) NS5 RNA-dependent RNA polymerase (RdRp), an important drug target, synthesizes viral RNA and is essential for viral replication. While a number of allosteric inhibitors have been reported for hepatitis C virus RdRp, few have been described for DENV RdRp. Following a diverse compound screening campaign and a rigorous hit-to-lead flowchart combining biochemical and biophysical approaches, two DENV RdRp nonnucleoside inhibitors were identified and characterized. These inhibitors show low- to high-micromolar inhibition in DENV RNA polymerization and cell-based assays. X-ray crystallography reveals that they bind in the enzyme RNA template tunnel. One compound (NITD-434) induced an allosteric pocket at the junction of the fingers and palm subdomains by displacing residue V603 in motif B. Binding of another compound (NITD-640) ordered the fingers loop preceding the F motif, close to the RNA template entrance. Most of the amino acid residues that interacted with these compounds are highly conserved in flaviviruses. Both sites are important for polymerase de novo initiation and elongation activities and essential for viral replication. This work provides evidence that the RNA tunnel in DENV RdRp offers interesting target sites for inhibition.IMPORTANCE Dengue virus (DENV), an important arthropod-transmitted human pathogen that causes a spectrum of diseases, has spread dramatically worldwide in recent years. Despite extensive efforts, the only commercial vaccine does not provide adequate protection to naive individuals. DENV NS5 polymerase is a promising drug target, as exemplified by the development of successful commercial drugs against hepatitis C virus (HCV) polymerase and HIV-1 reverse transcriptase. High-throughput screening of compound libraries against this enzyme enabled the discovery of inhibitors that induced binding sites in the RNA template channel. Characterizations by biochemical, biophysical, and reverse genetics approaches provide a better understanding of the biological relevance of these allosteric sites and the way forward to design more-potent inhibitors. National Research Foundation (NRF) Published version The J.L. lab was supported by grant NRF2016-CRP001-063. Use of the Industrial Macromolecular Crystallography Association Collaborative Access Team (IMCA-CAT) beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357.
- Published
- 2020
6. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
- Author
-
Steven E. Bosinger, Shamika Bedoya, Philipp Ralfs, Kathryn L. Pellegrini, Arash Grakoui, Anice C. Lowen, Eric J. Sorscher, Bernardo A. Mainou, Hadj S. Aoued, Amit A. Upadhyay, Larry J. Anderson, Jenna L. Lobby, Candela Manfredi, Tatiana Chirkova, Jacob E. Kohlmeier, Vineet D. Menachery, Abigail Vanderheiden, Gregory M. Tharp, Mehul S. Suthar, Pei Yong Shi, and Matthew G. Zimmerman
- Subjects
Chemokine ,viruses ,Cellular Response to Infection ,medicine.disease_cause ,Virus Replication ,Madin Darby Canine Kidney Cells ,Interferon Lambda ,0302 clinical medicine ,Interferon ,Chlorocebus aethiops ,Lung ,Cells, Cultured ,Coronavirus ,0303 health sciences ,biology ,030220 oncology & carcinogenesis ,Interferon Type I ,Cytokines ,Chemokines ,Coronavirus Infections ,medicine.drug ,Immunology ,Pneumonia, Viral ,Bronchi ,Microbiology ,Virus ,Proinflammatory cytokine ,Cell Line ,03 medical and health sciences ,Betacoronavirus ,Immune system ,Dogs ,Virology ,medicine ,Animals ,Humans ,Interleukin 8 ,Pandemics ,Vero Cells ,030304 developmental biology ,Innate immune system ,SARS-CoV-2 ,fungi ,COVID-19 ,Epithelial Cells ,respiratory tract diseases ,Insect Science ,biology.protein ,Interferons - Abstract
The newly emerged human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a pandemic of respiratory illness. Current evidence suggests that severe cases of SARS-CoV-2 are associated with a dysregulated immune response. However, little is known about how the innate immune system responds to SARS-CoV-2. In this study, we modeled SARS-CoV-2 infection using primary human airway epithelial (pHAE) cultures, which are maintained in an air-liquid interface. We found that SARS-CoV-2 infects and replicates in pHAE cultures and is directionally released on the apical, but not basolateral, surface. Transcriptional profiling studies found that infected pHAE cultures had a molecular signature dominated by proinflammatory cytokines and chemokine induction, including interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), and CXCL8, and identified NF-κB and ATF-4 as key drivers of this proinflammatory cytokine response. Surprisingly, we observed a complete lack of a type I or III interferon (IFN) response to SARS-CoV-2 infection. However, pretreatment and posttreatment with type I and III IFNs significantly reduced virus replication in pHAE cultures that correlated with upregulation of antiviral effector genes. Combined, our findings demonstrate that SARS-CoV-2 does not trigger an IFN response but is sensitive to the effects of type I and III IFNs. Our studies demonstrate the utility of pHAE cultures to model SARS-CoV-2 infection and that both type I and III IFNs can serve as therapeutic options to treat COVID-19 patients. IMPORTANCE The current pandemic of respiratory illness, COVID-19, is caused by a recently emerged coronavirus named SARS-CoV-2. This virus infects airway and lung cells causing fever, dry cough, and shortness of breath. Severe cases of COVID-19 can result in lung damage, low blood oxygen levels, and even death. As there are currently no vaccines approved for use in humans, studies of the mechanisms of SARS-CoV-2 infection are urgently needed. Our research identifies an excellent system to model SARS-CoV-2 infection of the human airways that can be used to test various treatments. Analysis of infection in this model system found that human airway epithelial cell cultures induce a strong proinflammatory cytokine response yet block the production of type I and III IFNs to SARS-CoV-2. However, treatment of airway cultures with the immune molecules type I or type III interferon (IFN) was able to inhibit SARS-CoV-2 infection. Thus, our model system identified type I or type III IFN as potential antiviral treatments for COVID-19 patients.
- Published
- 2020
7. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection
- Author
-
Zayed Attia, Mark E. Peeples, Anzhong Li, Pei Yong Shi, Xueya Liang, Jingyou Yu, Mijia Lu, Shan-Lu Liu, Thomas Z. Gao, Miaoge Xue, Chao Shan, Jianrong Li, and Prosper N. Boyaka
- Subjects
viruses ,Immunology ,Viremia ,Receptor, Interferon alpha-beta ,Cross Reactions ,Viral Nonstructural Proteins ,Antibodies, Viral ,Microbiology ,Vesicular stomatitis Indiana virus ,Zika virus ,Dengue fever ,DNA vaccination ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Virology ,Vaccines and Antiviral Agents ,Vaccines, DNA ,medicine ,Animals ,Antibody-dependent enhancement ,030212 general & internal medicine ,030304 developmental biology ,Mice, Knockout ,Mice, Inbred BALB C ,0303 health sciences ,biology ,Zika Virus Infection ,Immunogenicity ,virus diseases ,Viral Vaccines ,Zika Virus ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,medicine.disease ,Antibodies, Neutralizing ,Disease Models, Animal ,Flavivirus ,Vesicular stomatitis virus ,Insect Science ,Female ,Vesicular Stomatitis - Abstract
The nonstructural protein 1 (NS1) of several flaviviruses, including West Nile, dengue, and yellow fever viruses, is capable of inducing variable degrees of protection against flavivirus infection in animal models. However, the immunogenicity of NS1 protein of Zika virus (ZIKV) is less understood. Here, we determined the efficacy of ZIKV NS1-based vaccine candidates using two delivery platforms, methyltransferase-defective recombinant vesicular stomatitis virus (mtdVSV) and a DNA vaccine. We first show that expression of ZIKV NS1 could be significantly enhanced by optimizing the signal peptide. A single dose of mtdVSV-NS1-based vaccine or two doses of DNA vaccine induced high levels of NS1-specfic antibody and T cell immune responses but provided only partial protection against ZIKV viremia in BALB/c mice. In Ifnar1(−/−) mice, neither NS1-based vaccine provided protection against a lethal high dose (10(5) PFU) ZIKV challenge, but mtdVSV-NS1-based vaccine prevented deaths from a low dose (10(3) PFU) challenge, though they experienced viremia and body weight loss. We conclude that ZIKV NS1 alone conferred substantial, but not complete, protection against ZIKV infection. Nevertheless, these results highlight the value of ZIKV NS1 for vaccine development. IMPORTANCE Most Zika virus (ZIKV) vaccine research has focused on the E or prM-E proteins and the induction of high levels of neutralizing antibodies. However, these ZIKV neutralizing antibodies cross-react with other flaviviruses, which may aggravate the disease via an antibody-dependent enhancement (ADE) mechanism. ZIKV NS1 protein may be an alternative antigen for vaccine development, since antibodies to NS1 do not bind to the virion, thereby eliminating the risk of ADE. Here, we show that recombinant VSV and DNA vaccines expressing NS1, alone, confer partial protection against ZIKV infection in both immunocompetent and immunodeficient mice, highlighting the value of NS1 as a potential vaccine candidate.
- Published
- 2020
8. Short Direct Repeats in the 3′ Untranslated Region Are Involved in Subgenomic Flaviviral RNA Production
- Author
-
Zhiming Yuan, Xiao-Dan Li, Han-Qing Ye, Xing Yao Huang, Cheng-Feng Qin, Xiaolin Niu, Na Li, Yan Peng Xu, Hao Long Dong, Bo Zhang, Qiu Yan Zhang, Xiaofeng Li, Hong Jiang Wang, Xianyang Fang, Peng Gong, Pei Yong Shi, Cheng Lin Deng, Qi Chen, and Hui Zhao
- Subjects
Untranslated region ,Immunology ,Genome, Viral ,Biology ,Microbiology ,Genome ,Conserved sequence ,Cricetinae ,Virology ,Exoribonuclease ,Chlorocebus aethiops ,Animals ,Humans ,Direct repeat ,3' Untranslated Regions ,Vero Cells ,Subgenomic mRNA ,Genetics ,Three prime untranslated region ,Flavivirus ,RNA ,Genome Replication and Regulation of Viral Gene Expression ,Culicidae ,A549 Cells ,Tandem Repeat Sequences ,Insect Science ,Nucleic Acid Conformation ,RNA, Viral - Abstract
Mosquito-borne flaviviruses consist of a positive-sense genome RNA flanked by the untranslated regions (UTRs). There is a panel of highly complex RNA structures in the UTRs with critical functions. For instance, Xrn1-resistant RNAs (xrRNAs) halt Xrn1 digestion, leading to the production of subgenomic flaviviral RNA (sfRNA). Conserved short direct repeats (DRs), also known as conserved sequences (CS) and repeated conserved sequences (RCS), have been identified as being among the RNA elements locating downstream of xrRNAs, but their biological function remains unknown. In this study, we revealed that the specific DRs are involved in the production of specific sfRNAs in both mammalian and mosquito cells. Biochemical assays and structural remodeling demonstrate that the base pairings in the stem of these DRs control sfRNA formation by maintaining the binding affinity of the corresponding xrRNAs to Xrn1. On the basis of these findings, we propose that DRs functions like a bracket holding the Xrn1-xrRNA complex for sfRNA formation. IMPORTANCE Flaviviruses include many important human pathogens. The production of subgenomic flaviviral RNAs (sfRNAs) is important for viral pathogenicity as a common feature of flaviviruses. sfRNAs are formed through the incomplete degradation of viral genomic RNA by the cytoplasmic 5ʹ–3ʹ exoribonuclease Xrn1 halted at the Xrn1-resistant RNA (xrRNA) structures within the 3ʹ-UTR. The 3ʹ-UTRs of the flavivirus genome also contain distinct short direct repeats (DRs), such as RCS3, CS3, RCS2, and CS2. However, the biological functions of these ancient primary DR sequences remain largely unknown. Here, we found that DR sequences are involved in sfRNA formation and viral virulence and provide novel targets for the rational design of live attenuated flavivirus vaccine.
- Published
- 2020
9. NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues
- Author
-
Tingjin Sherryl Soh, Siew Pheng Lim, Pei Yong Shi, Aïcha Gharbi-Ayachi, Cheah Chen Seh, Abbas El Sahili, Jonas Schiltz, Julien Lescar, School of Biological Sciences, NTU Institute of Structural Biology, Antimicrobial Resistance Interdisciplinary Research Group, and Singapore-MIT Alliance Programme
- Subjects
Models, Molecular ,Protein Conformation, alpha-Helical ,Viral protein ,viruses ,Immunology ,Genetic Vectors ,RNA-dependent RNA polymerase ,Gene Expression ,Dengue virus ,Biology ,Viral Nonstructural Proteins ,medicine.disease_cause ,Crystallography, X-Ray ,Serogroup ,Microbiology ,Virus ,Zika virus ,Virology ,medicine ,Escherichia coli ,Humans ,Protein Interaction Domains and Motifs ,Replicon ,Amino Acid Sequence ,Cloning, Molecular ,Encephalitis Virus, Japanese ,Binding Sites ,Flaviviruses ,Structure and Assembly ,Biological sciences [Science] ,virus diseases ,Zika Virus ,Dengue Virus ,biology.organism_classification ,Recombinant Proteins ,Flavivirus ,Viral replication ,Structural Homology, Protein ,Insect Science ,Mutation ,Protein Conformation, beta-Strand ,Protein Multimerization ,Sequence Alignment ,Protein Binding - Abstract
Flavivirus nonstructural protein 5 (NS5) contains an N-terminal methyltransferase (MTase) domain and a C-terminal polymerase (RNA-dependent RNA polymerase [RdRp]) domain fused through a 9-amino-acid linker. While the individual NS5 domains are structurally conserved, in the full-length protein, their relative orientations fall into two classes: the NS5 proteins from Japanese encephalitis virus (JEV) and Zika virus (ZIKV) adopt one conformation, while the NS5 protein from dengue virus serotype 3 (DENV3) adopts another. Here, we report a crystallographic structure of NS5 from DENV2 in a conformation similar to the extended one seen in JEV and ZIKV NS5 crystal structures. Replacement of the DENV2 NS5 linker with DENV1, DENV3, DENV4, JEV, and ZIKV NS5 linkers had modest or minimal effects on in vitro DENV2 MTase and RdRp activities. Heterotypic DENV NS5 linkers attenuated DENV2 replicon growth in cells, while the JEV and ZIKV NS5 linkers abolished replication. Thus, the JEV and ZIKV linkers likely hindered essential DENV2 NS5 interactions with other viral or host proteins within the virus replicative complex. Overall, this work sheds light on the dynamics of the multifunctional flavivirus NS5 protein and its interdomain linker. Targeting the NS5 linker is a possible strategy for producing attenuated flavivirus strains for vaccine design. IMPORTANCE Flaviviruses include important human pathogens, such as dengue virus and Zika virus. NS5 is a nonstructural protein essential for flavivirus RNA replication with dual MTase and RdRp enzyme activities and thus constitutes a major drug target. Insights into NS5 structure, dynamics, and evolution should inform the development of antiviral inhibitors and vaccine design. We found that NS5 from DENV2 can adopt a conformation resembling that of NS5 from JEV and ZIKV. Replacement of the DENV2 NS5 linker with the JEV and ZIKV NS5 linkers abolished DENV2 replication in cells, without significantly impacting in vitro DENV2 NS5 enzymatic activities. We propose that heterotypic flavivirus NS5 linkers impede DENV2 NS5 protein-protein interactions that are essential for virus replication.
- Published
- 2019
10. Zika Virus NS2A-Mediated Virion Assembly
- Author
-
Jing Zou, Xinwen Chen, Xuping Xie, Pei Yong Shi, Xianwen Zhang, Vsevolod L. Popov, Hongjie Xia, and Linfen Huang
- Subjects
Untranslated region ,Molecular Biology and Physiology ,Immunoprecipitation ,viruses ,Genome, Viral ,Biology ,Viral Nonstructural Proteins ,Virus Replication ,Microbiology ,Virus ,03 medical and health sciences ,Viral Proteins ,Zika ,Viral Envelope Proteins ,Pregnancy ,Virology ,Humans ,Nucleocapsid ,030304 developmental biology ,0303 health sciences ,NS3 ,Zika Virus Infection ,Flavivirus ,Virus Assembly ,030302 biochemistry & molecular biology ,Serine Endopeptidases ,virus diseases ,RNA ,Zika Virus ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,QR1-502 ,3. Good health ,Cell biology ,Capsid ,Virion assembly ,Mutation ,RNA, Viral ,Female ,Research Article ,Peptide Hydrolases - Abstract
ZIKV is a recently emerged mosquito-borne flavivirus that can cause devastating congenital Zika syndrome in pregnant women and Guillain-Barré syndrome in adults. The molecular mechanism of ZIKV virion assembly is largely unknown. Here, we report that ZIKV NS2A plays a central role in recruiting viral RNA, structural protein prM/E, and viral NS2B/NS3 protease to the virion assembly site and orchestrating virion morphogenesis. One mutation that impairs these interactions does not significantly affect viral RNA replication but selectively abolishes virion assembly, demonstrating the specific role of these interactions in virus morphogenesis. We also show that the 3ʹ UTR of ZIKV RNA may serve as a “recruitment signal” through binding to NS2A to enter the virion assembly site. Following a coordinated cleavage of C-prM-E at the virion assembly site, NS2A may present the viral RNA to C protein for nucleocapsid formation followed by envelopment with prM/E proteins. The results have provided new insights into flavivirus virion assembly., The flavivirus virion consists of an envelope outer layer, formed by envelope (E) and membrane (M) proteins on a lipid bilayer, and an internal core, formed by capsid (C) protein and genomic RNA. The molecular mechanism of flavivirus assembly is not well understood. Here, we show that Zika virus (ZIKV) NS2A protein recruits genomic RNA, the structural protein prM/E complex, and the NS2B/NS3 protease complex to the virion assembly site and orchestrates virus morphogenesis. Coimmunoprecipitation analysis showed that ZIKV NS2A binds to prM, E, NS2B, and NS3 (but not C, NS4B, or NS5) in a viral RNA-independent manner, whereas prM/E complex does not interact with NS2B/NS3 complex. Remarkably, a single-amino-acid mutation (E103A) of NS2A impairs its binding to prM/E and NS2B/NS3 and abolishes virus production, demonstrating the indispensable role of NS2A/prM/E and NS2A/NS2B/NS3 interactions in virion assembly. In addition, RNA-protein pulldown analysis identified a stem-loop RNA from the 3ʹ untranslated region (UTR) of the viral genome as an “RNA recruitment signal” for ZIKV assembly. The 3ʹ UTR RNA binds to a cytoplasmic loop of NS2A protein. Mutations of two positively charged residues (R96A and R102A) from the cytoplasmic loop reduce NS2A binding to viral RNA, leading to a complete loss of virion assembly. Collectively, our results support a virion assembly model in which NS2A recruits viral NS2B/NS3 protease and structural C-prM-E polyprotein to the virion assembly site; once the C-prM-E polyprotein has been processed, NS2A presents viral RNA to the structural proteins for virion assembly.
- Published
- 2019
11. Evaluation of a Novel Reporter Virus Neutralization Test for Serological Diagnosis of Zika and Dengue Virus Infection
- Author
-
Ping Ren, Michael J. Loeffelholz, Laura D. Kramer, Daniel Ortiz, Pei Yong Shi, Yujiao Yang, Susan J. Wong, and Chao Shan
- Subjects
0301 basic medicine ,Microbiology (medical) ,specificity ,Virus Neutralization ,Enzyme-Linked Immunosorbent Assay ,Viremia ,Dengue virus ,Antibodies, Viral ,medicine.disease_cause ,Sensitivity and Specificity ,Cell Line ,Zika virus ,Serology ,Dengue ,03 medical and health sciences ,Plaque reduction neutralization test ,Neutralization Tests ,neutralization assay ,Virology ,Chlorocebus aethiops ,medicine ,Animals ,Humans ,Vero Cells ,dengue virus ,biology ,Zika Virus Infection ,business.industry ,Reproducibility of Results ,Zika Virus ,sensitivity ,biology.organism_classification ,medicine.disease ,Antibodies, Neutralizing ,3. Good health ,Titer ,030104 developmental biology ,Immunoglobulin M ,biology.protein ,Antibody ,business - Abstract
Currently, the laboratory diagnosis of Zika virus (ZIKV) infection is primarily through the detection of ZIKV RNA or antibodies against ZIKV proteins. The detection of viral RNA is highly sensitive and specific, but periods of viremia and viruria are brief, limiting the utility of ZIKV RNA assays. Instead, most ZIKV infections are diagnosed serologically, using an IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) for screening, followed by a confirmatory plaque reduction neutralization test (PRNT). Typical turnaround times vary, due to assay incubation periods and a lack of clinical laboratories performing these tests. Recently, a novel luciferase-ZIKV- and -dengue virus (DENV)-based serological assay, which considerably improves the turnaround times and throughput for ZIKV diagnosis, was described. Using the traditional PRNT as a reference method, we evaluated the performance characteristics of the reporter virus neutralization test (RVNT) with 258 clinical serum specimens. The ZIKV RVNT produced primary ZIKV screening and secondary confirmation results in 4 days, with 100% reproducibility. As a screening assay, the ZIKV RVNT displayed excellent diagnostic accuracy, sensitivity, and specificity of 98.2%, 100%, and 98.1%, respectively. As a confirmatory assay, the ZIKV RVNT titers displayed 93.1% agreement with the traditional ZIKV PRNT titers. Overall, the RVNT accurately and reliably detects neutralizing antibodies in patient serum specimens, with improved turnaround times, and can be used for the serological detection of ZIKV infections. Due to the homogeneous 96-well format, the RVNT has also significantly improved the assay throughput to allow testing of a large number of specimens in a single run.
- Published
- 2017
12. Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus
- Author
-
Na Li, Zhiming Yuan, Ya-Nan Zhang, Pei Yong Shi, Bo Zhang, and Cheng Lin Deng
- Subjects
animal diseases ,viruses ,Immunology ,Receptor, Interferon alpha-beta ,Viral Nonstructural Proteins ,Antibodies, Viral ,Virus Replication ,Microbiology ,Virus ,03 medical and health sciences ,Gene Knockout Techniques ,Mice ,Immunity ,Virology ,Vaccines and Antiviral Agents ,Chlorocebus aethiops ,Animals ,Humans ,Vero Cells ,030304 developmental biology ,Sequence Deletion ,0303 health sciences ,biology ,030306 microbiology ,virus diseases ,Viral Vaccines ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,nervous system diseases ,Vaccination ,Flavivirus ,Disease Models, Animal ,HEK293 Cells ,Viral replication ,Immunization ,Insect Science ,biology.protein ,Vero cell ,Antibody ,West Nile virus ,West Nile Fever - Abstract
We previously produced a replication-defective West Nile virus (WNV) lacking NS1 (WNV-ΔNS1) that could propagate at low levels (105 infectious units [IU]/ml) in a 293T cell line expressing wild-type (WT) NS1. This finding indicates the potential of developing WNV-ΔNS1 as a noninfectious vaccine. To explore this idea, we developed an NS1-expressing Vero cell line (VeroNS1) that significantly improved the yield of WNV-ΔNS1 (108 IU/ml). We evaluated the safety and efficacy of WNV-ΔNS1 in mice. WNV-ΔNS1 appeared to be safe, as no replicative virus was found in naive Vero cells after continuous culturing of WNV-ΔNS1 in VeroNS1 cells for 15 rounds. WNV-ΔNS1 was noninfectious in mice, even when IFNAR−/− mice were administered a high dose of WNV-ΔNS1. Vaccination with a single dose of WNV-ΔNS1 protected mice from a highly lethal challenge with WT WNV. The antibody response against WNV correlated well with the protection of vaccinated mice. Our study demonstrates the potential of the NS1 trans complementation system as a new platform for flavivirus vaccine development. IMPORTANCE Many flaviviruses are significant human pathogens that frequently cause outbreaks and epidemics around the world. Development of novel vaccine platforms against these pathogens is a public health priority. Using WNV as a model, we developed a new vaccine platform for flaviviruses. WNV containing a NS1 deletion (WNV-ΔNS1) could be efficiently trans complemented in Vero cells that constitutively expressed WT NS1 protein. A single-dose immunization with WNV-ΔNS1 elicited robust immune responses in mice. The immunized animals were fully protected against pathogenic WNV infection. No adverse effects related to the WNV-ΔNS1 vaccination were observed. The results have demonstrated the potential of the NS1 complementation system as an alternative platform for flavivirus vaccine development, especially for highly pathogenic flaviviruses.
- Published
- 2019
13. Erratum for Chen et al., 'Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate'
- Author
-
Pei Yong Shi, Jianghong Man, Jin Wu, Chao Shan, Xiaofeng Li, Tongyan Zhao, Feng Ma, Cheng-Feng Qin, Dapei Li, Yan Wu, Qi Chen, Qing Ye, Xuping Xie, Chunfeng Li, Haitao Wu, Qian Zhu, Xiaoling Qin, and Xiaoyan Zhan
- Subjects
Mice, Nude ,Apoptosis ,Vaccines, Attenuated ,Microbiology ,Zika virus ,Mice ,03 medical and health sciences ,Virology ,Chlorocebus aethiops ,Animals ,Humans ,Medicine ,Vero Cells ,030304 developmental biology ,Inflammation ,Oncolytic Virotherapy ,Mice, Inbred BALB C ,0303 health sciences ,biology ,Brain Neoplasms ,030306 microbiology ,business.industry ,Published Erratum ,Zika Virus ,biology.organism_classification ,medicine.disease ,Xenograft Model Antitumor Assays ,QR1-502 ,Mice, Inbred C57BL ,Oncolytic Viruses ,Viral Tropism ,Neoplastic Stem Cells ,Female ,Erratum ,Glioblastoma ,business - Abstract
Glioblastoma (GBM) is the deadliest type of brain tumor, and glioma stem cells (GSCs) contribute to tumor recurrence and therapeutic resistance. Thus, an oncolytic virus targeting GSCs may be useful for improving GBM treatment. Because Zika virus (ZIKV) has an oncolytic tropism for infecting GSCs, we investigated the safety and efficacy of a live attenuated ZIKV vaccine candidate (ZIKV-LAV) for the treatment of human GBM in a GSC-derived orthotopic model. Intracerebral injection of ZIKV-LAV into mice caused no neurological symptoms or behavioral abnormalities. The neurovirulence of ZIKV-LAV was more attenuated than that of the licensed Japanese encephalitis virus LAV 14-14-2, underlining the superior safety of ZIKV-LAV for potential GBM treatment. Importantly, ZIKV-LAV significantly reduced intracerebral tumor growth and prolonged animal survival by selectively killing GSCs within the tumor. Mechanistically, ZIKV infection elicited antiviral immunity, inflammation, and GSC apoptosis. Together, these results further support the clinical development of ZIKV-LAV for GBM therapy.
- Published
- 2019
14. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
- Author
-
Xiaoling Qin, Haitao Wu, Pei Yong Shi, Jianghong Man, Cheng-Feng Qin, Qing Ye, Qi Chen, Qian Zhu, Xiaoyan Zhan, Tongyang Zhao, Dapei Li, Chao Shan, Jin Wu, Feng Ma, Yan Wu, Xiaofeng Li, Xuping Xie, and Chunfeng Li
- Subjects
0301 basic medicine ,endocrine system ,medicine.medical_treatment ,Brain tumor ,Microbiology ,Virus ,Zika virus ,03 medical and health sciences ,Virology ,Glioma ,vaccine ,Medicine ,anticancer therapy ,Tropism ,Chemotherapy ,biology ,business.industry ,glioblastoma ,medicine.disease ,biology.organism_classification ,QR1-502 ,Oncolytic virus ,030104 developmental biology ,Cancer research ,Stem cell ,business - Abstract
Glioblastoma (GBM) is the deadliest type of brain tumor, and glioma stem cells (GSCs) contribute to tumor recurrence and therapeutic resistance. Thus, an oncolytic virus targeting GSCs may be useful for improving GBM treatment. Because Zika virus (ZIKV) has an oncolytic tropism for infecting GSCs, we investigated the safety and efficacy of a live attenuated ZIKV vaccine candidate (ZIKV-LAV) for the treatment of human GBM in a GSC-derived orthotopic model. Intracerebral injection of ZIKV-LAV into mice caused no neurological symptoms or behavioral abnormalities. The neurovirulence of ZIKV-LAV was more attenuated than that of the licensed Japanese encephalitis virus LAV 14-14-2, underlining the superior safety of ZIKV-LAV for potential GBM treatment. Importantly, ZIKV-LAV significantly reduced intracerebral tumor growth and prolonged animal survival by selectively killing GSCs within the tumor. Mechanistically, ZIKV infection elicited antiviral immunity, inflammation, and GSC apoptosis. Together, these results further support the clinical development of ZIKV-LAV for GBM therapy. IMPORTANCE Glioblastoma (GBM), the deadliest type of brain tumor, is currently incurable because of its high recurrence rate after traditional treatments, including surgery to remove the main part of the tumor and radiation and chemotherapy to target residual tumor cells. These treatments fail mainly due to the presence of a cell subpopulation called glioma stem cells (GSCs), which are resistant to radiation and chemotherapy and capable of self-renewal and tumorigenicity. Because Zika virus (ZIKV) has an oncolytic tropism for infecting GSCs, we tested a live attenuated ZIKV vaccine candidate (ZIKV-LAV) for the treatment of human GBM in a human GSC-derived orthotopic model. Our results showed that ZIKV-LAV retained good efficacy against glioblastoma by selectively killing GSCs within the tumor. In addition, ZIKV-LAV exhibited an excellent safety profile upon intracerebral injection into the treated animals. The good balance between the safety of ZIKV-LAV and its efficacy against human GSCs suggests that it is a potential candidate for combination with the current treatment regimen for GBM therapy.
- Published
- 2018
15. Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach
- Author
-
Pei Yong Shi, Roland Züst, Jason M. Mackenzie, Xuping Xie, Jing Zou, Katja Fink, Bo Zhang, Chao Shan, and Rebecca L Ambrose
- Subjects
Male ,0301 basic medicine ,viruses ,030106 microbiology ,Immunology ,Dengue Vaccines ,Viral Nonstructural Proteins ,Dengue virus ,Biology ,Virus Replication ,medicine.disease_cause ,Microbiology ,Defective virus ,Virus ,Dengue fever ,Dengue ,Mice ,03 medical and health sciences ,Virology ,Vaccines and Antiviral Agents ,medicine ,Animals ,Humans ,Dengue vaccine ,Virus Assembly ,Defective Viruses ,Dengue Virus ,Japanese encephalitis ,medicine.disease ,Antibodies, Neutralizing ,030104 developmental biology ,Viral replication ,Virion assembly ,Insect Science ,Mutation ,RNA, Viral ,Female - Abstract
Dengue virus (DENV) is the most prevalent mosquito-transmitted viral pathogen in humans. The recently licensed dengue vaccine has major weaknesses. Therefore, there is an urgent need to develop improved dengue vaccines. Here, we report a virion assembly-defective DENV as a vaccine platform. DENV containing an amino acid deletion (K188) in nonstructural protein 2A (NS2A) is fully competent in viral RNA replication but is completely defective in virion assembly. When trans-complemented with wild-type NS2A protein, the virion assembly defect could be rescued, generating pseudoinfectious virus (PIV(NS2A)) that could initiate single-round infection. The trans-complementation efficiency could be significantly improved through selection for adaptive mutations, leading to high-yield PIV(NS2A) production, with titers of >10(7) infectious-focus units (IFU)/ml. Mice immunized with a single dose of PIV(NS2A) elicited strong T cell immune responses and neutralization antibodies and were protected from wild-type-virus challenge. Collectively, the results proved the concept of using assembly-defective virus as a vaccine approach. The study also solved the technical bottleneck in producing high yields of PIV(NS2A) vaccine. The technology could be applicable to vaccine development for other viral pathogens. IMPORTANCE Many flaviviruses are significant human pathogens that pose global threats to public health. Although licensed vaccines are available for yellow fever, Japanese encephalitis, tick-borne encephalitis, and dengue viruses, new approaches are needed to develop improved vaccines. Using dengue virus as a model, we developed a vaccine platform using a virion assembly-defective virus. We show that such an assembly-defective virus could be rescued to higher titers and infect cells for a single round. Mice immunized with the assembly-defective virus were protected from wild-type-virus infection. This vaccine approach could be applicable to other viral pathogens.
- Published
- 2018
16. Flexibility of NS5 Methyltransferase-Polymerase Linker Region Is Essential for Dengue Virus Replication
- Author
-
Dahai Luo, Tingjin Sherryl Soh, Subhash G. Vasudevan, Siew Pheng Lim, Julien Lescar, Thomas Huber, Kunchithapadam Swaminathan, Sarah Suet Yin Fung, Kitti Wing Ki Chan, Pei Yong Shi, Yongqian Zhao, Diamond, M. S., Lee Kong Chian School of Medicine (LKCMedicine), and School of Biological Sciences
- Subjects
viruses ,Molecular Sequence Data ,Immunology ,Gene Expression ,Mutagenesis (molecular biology technique) ,Sequence alignment ,Molecular Dynamics Simulation ,Viral Nonstructural Proteins ,Dengue virus ,Crystallography, X-Ray ,Virus Replication ,medicine.disease_cause ,Microbiology ,Protein Structure, Secondary ,Cell Line ,Cricetulus ,Virology ,medicine ,Animals ,Humans ,Amino Acid Sequence ,Polymerase ,Mutation ,biology ,Structure and Assembly ,virus diseases ,Dengue Virus ,Recombinant Proteins ,Reverse genetics ,Protein Structure, Tertiary ,Viral replication ,Biochemistry ,Insect Science ,biology.protein ,RNA, Viral ,Sequence Alignment ,Linker - Abstract
We examined the function of the conserved Val/Ile residue within the dengue virus NS5 interdomain linker (residues 263 to 272) by site-directed mutagenesis. Gly substitution or Gly/Pro insertion after the conserved residue increased the linker flexibility and created slightly attenuated viruses. In contrast, Pro substitution abolished virus replication by imposing rigidity in the linker and restricting NS5's conformational plasticity. Our biochemical and reverse genetics experiments demonstrate that NS5 utilizes conformational regulation to achieve optimum viral replication.
- Published
- 2015
17. Zika Virus Infects Human Sertoli Cells and Modulates the Integrity of the In Vitro Blood-Testis Barrier Model
- Author
-
David N. Siemann, Pei Yong Shi, Payal N. Maharaj, Daniel P. Strange, and Saguna Verma
- Subjects
0301 basic medicine ,Male ,Sexual transmission ,030106 microbiology ,Immunology ,Alpha interferon ,Vascular Cell Adhesion Molecule-1 ,Receptors, Cell Surface ,Dengue virus ,Biology ,medicine.disease_cause ,Microbiology ,Dengue ,03 medical and health sciences ,Virology ,medicine ,Humans ,Claudin ,Blood-Testis Barrier ,Cells, Cultured ,Blood–testis barrier ,Innate immune system ,Sertoli Cells ,Cell adhesion molecule ,Zika Virus Infection ,Macrophages ,Interferon-alpha ,Zika Virus ,Dengue Virus ,Sertoli cell ,Cell biology ,Virus-Cell Interactions ,030104 developmental biology ,medicine.anatomical_structure ,Insect Science ,Claudins ,Zonula Occludens-1 Protein ,Cell Adhesion Molecules - Abstract
Confirmed reports of Zika virus (ZIKV) in human seminal fluid for months after the clearance of viremia suggest the ability of ZIKV to establish persistent infection in the seminiferous tubules, an immune-privileged site in the testis protected by the blood-testis barrier, also called the Sertoli cell (SC) barrier (SCB). However, cellular targets of ZIKV in human testis and mechanisms by which the virus enters seminiferous tubules remain unclear. We demonstrate that primary human SCs were highly susceptible to ZIKV compared to the closely related dengue virus and induced the expression of alpha interferon (IFN-α), key cytokines, and cell adhesion molecules (vascular cell adhesion molecule 1 [VCAM-1] and intracellular adhesion molecule 1 [ICAM-1]). Furthermore, using an in vitro SCB model, we show that ZIKV was released on the adluminal side of the SCB model with a higher efficiency than in the blood-brain barrier model. ZIKV-infected SCs exhibited enhanced adhesion of leukocytes that correlated with decreases in SCB integrity. ZIKV infection did not affect the expression of tight and adherens junction proteins such as ZO-1, claudin, and JAM-A; however, exposure of SCs to inflammatory mediators derived from ZIKV-infected macrophages led to the degradation of the ZO-1 protein, which correlated with increased SCB permeability. Taken together, our data suggest that infection of SCs may be one of the crucial steps by which ZIKV gains access to the site of spermatozoon development and identify SCs as a therapeutic target to clear testicular infections. The SCB model opens up opportunities to assess interactions of SCs with other testicular cells and to test the ability of anti-ZIKV drugs to cross the barrier. IMPORTANCE Recent outbreaks of ZIKV, a neglected mosquito-borne flavivirus, have identified sexual transmission as a new route of disease spread, which has not been reported for other flaviviruses. To be able to sexually transmit for months after the clearance of viremia, ZIKV must establish infection in the seminiferous tubules, the site of spermatozoon development. However, little is known about the cell types that support ZIKV infection in the human testis. Currently, there are no models to study mechanisms of virus persistence in the seminiferous tubules. We provide evidence that ZIKV infection of human Sertoli cells, which are an important component of the seminiferous tubules, is robust and induces a strong antiviral response. The use of an in vitro Sertoli cell barrier to describe how ZIKV or inflammatory mediators derived from ZIKV-infected macrophages compromise barrier integrity will enable studies to explore the interactions of other testicular cells with Sertoli cells and to test novel antivirals for clearing testicular ZIKV infection.
- Published
- 2017
18. Discovery of Dengue Virus NS4B Inhibitors
- Author
-
Julien Lescar, Feng Gu, Kah Fei Wan, Francesca Blasco, CongBao Kang, Wai Ling Chan, Wei Liu, Paul W. Smith, Agatha Susila, Bin Zou, Qing Yin Wang, K.L. Yeo, Mei Ding, Chao Shan, Andy M. Yip, Haoying Xu, Hongping Dong, Jing Zou, Suresh B. Lakshminarayana, Ratna Karuna, Pei Yong Shi, Peck Gee Seah, Diamond, M. S., and School of Biological Sciences
- Subjects
viruses ,Immunology ,Viremia ,Viral Nonstructural Proteins ,Dengue virus ,Biology ,medicine.disease_cause ,Antiviral Agents ,Microbiology ,Cell Line ,In vivo ,Cricetinae ,Virology ,Vaccines and Antiviral Agents ,Drug Discovery ,medicine ,Animals ,Humans ,Spiro Compounds ,Replicon ,chemistry.chemical_classification ,Drug discovery ,virus diseases ,Dengue Virus ,biochemical phenomena, metabolism, and nutrition ,medicine.disease ,In vitro ,Amino acid ,chemistry ,Insect Science ,Viral replication complex - Abstract
The four serotypes of dengue virus (DENV-1 to -4) represent the most prevalent mosquito-borne viral pathogens in humans. No clinically approved vaccine or antiviral is currently available for DENV. Here we report a spiropyrazolopyridone compound that potently inhibits DENV both in vitro and in vivo . The inhibitor was identified through screening of a 1.8-million-compound library by using a DENV-2 replicon assay. The compound selectively inhibits DENV-2 and -3 (50% effective concentration [EC 50 ], 10 to 80 nM) but not DENV-1 and -4 (EC 50 , >20 μM). Resistance analysis showed that a mutation at amino acid 63 of DENV-2 NS4B (a nonenzymatic transmembrane protein and a component of the viral replication complex) could confer resistance to compound inhibition. Genetic studies demonstrate that variations at amino acid 63 of viral NS4B are responsible for the selective inhibition of DENV-2 and -3. Medicinal chemistry improved the physicochemical properties of the initial “hit” (compound 1), leading to compound 14a, which has good in vivo pharmacokinetics. Treatment of DENV-2-infected AG129 mice with compound 14a suppressed viremia, even when the treatment started after viral infection. The results have proven the concept that inhibitors of NS4B could potentially be developed for clinical treatment of DENV infection. Compound 14a represents a potential preclinical candidate for treatment of DENV-2- and -3-infected patients. IMPORTANCE Dengue virus (DENV) threatens up to 2.5 billion people and is now spreading in many regions in the world where it was not previously endemic. While there are several promising vaccine candidates in clinical trials, approved vaccines or antivirals are not yet available. Here we describe the identification and characterization of a spiropyrazolopyridone as a novel inhibitor of DENV by targeting the viral NS4B protein. The compound potently inhibits two of the four serotypes of DENV (DENV-2 and -3) both in vitro and in vivo . Our results validate, for the first time, that NS4B inhibitors could potentially be developed for antiviral therapy for treatment of DENV infection in humans.
- Published
- 2015
19. Characterization of Dengue Virus NS4A and NS4B Protein Interaction
- Author
-
CongBao Kang, Zhiming Yuan, Qing Yin Wang, Xuping Xie, Michelle Yueqi Lee, Hongping Dong, Pei Yong Shi, and Jing Zou
- Subjects
Magnetic Resonance Spectroscopy ,Protein Conformation ,viruses ,DNA Mutational Analysis ,Immunology ,Plasma protein binding ,Viral Nonstructural Proteins ,Biology ,Dengue virus ,Virus Replication ,medicine.disease_cause ,Microbiology ,Cell Line ,Protein structure ,Cricetinae ,Virology ,Protein Interaction Mapping ,medicine ,Animals ,Humans ,Protein secondary structure ,chemistry.chemical_classification ,Structure and Assembly ,Endoplasmic reticulum ,Dengue Virus ,Recombinant Proteins ,Amino acid ,Transmembrane domain ,Viral replication ,Biochemistry ,chemistry ,Insect Science ,Protein Binding - Abstract
Flavivirus replication is mediated by a membrane-associated replication complex where viral membrane proteins NS2A, NS2B, NS4A, and NS4B serve as the scaffold for the replication complex formation. Here, we used dengue virus serotype 2 (DENV-2) as a model to characterize viral NS4A-NS4B interaction. NS4A interacts with NS4B in virus-infected cells and in cells transiently expressing NS4A and NS4B in the absence of other viral proteins. Recombinant NS4A and NS4B proteins directly bind to each other with an estimated K d (dissociation constant) of 50 nM. Amino acids 40 to 76 (spanning the first transmembrane domain, consisting of amino acids 50 to 73) of NS4A and amino acids 84 to 146 (also spanning the first transmembrane domain, consisting of amino acids 101 to 129) of NS4B are the determinants for NS4A-NS4B interaction. Nuclear magnetic resonance (NMR) analysis suggests that NS4A residues 17 to 80 form two amphipathic helices (helix α1, comprised of residues 17 to 32, and helix α2, comprised of residues 40 to 47) that associate with the cytosolic side of endoplasmic reticulum (ER) membrane and helix α3 (residues 52 to 75) that transverses the ER membrane. In addition, NMR analysis identified NS4A residues that may participate in the NS4A-NS4B interaction. Amino acid substitution of these NS4A residues exhibited distinct effects on viral replication. Three of the four NS4A mutations (L48A, T54A, and L60A) that affected the NS4A-NS4B interaction abolished or severely reduced viral replication; in contrast, two NS4A mutations (F71A and G75A) that did not affect NS4A-NS4B interaction had marginal effects on viral replication, demonstrating the biological relevance of the NS4A-NS4B interaction to DENV-2 replication. Taken together, the study has provided experimental evidence to argue that blocking the NS4A-NS4B interaction could be a potential antiviral approach. IMPORTANCE Flavivirus NS4A and NS4B proteins are essential components of the ER membrane-associated replication complex. The current study systematically characterizes the interaction between flavivirus NS4A and NS4B. Using DENV-2 as a model, we show that NS4A interacts with NS4B in virus-infected cells, in cells transiently expressing NS4A and NS4B proteins, or in vitro with recombinant NS4A and NS4B proteins. We mapped the minimal regions required for the NS4A-NS4B interaction to be amino acids 40 to 76 of NS4A and amino acids 84 to 146 of NS4B. NMR analysis revealed the secondary structure of amino acids 17 to 80 of NS4A and the NS4A amino acids that may participate in the NS4A-NS4B interaction. Functional analysis showed a correlation between viral replication and NS4A-NS4B interaction, demonstrating the biological importance of the NS4A-NS4B interaction. The study has advanced our knowledge of the molecular function of flavivirus NS4A and NS4B proteins. The results also suggest that inhibitors of the NS4A-NS4B interaction could be pursued for flavivirus antiviral development.
- Published
- 2015
20. Two Distinct Sets of NS2A Molecules Are Responsible for Dengue Virus RNA Synthesis and Virion Assembly
- Author
-
Xuping Xie, Zhiming Yuan, Chunya Puttikhunt, Jing Zou, and Pei Yong Shi
- Subjects
viruses ,DNA Mutational Analysis ,Immunology ,Mutant ,RNA-dependent RNA polymerase ,Viral Nonstructural Proteins ,Dengue virus ,Biology ,medicine.disease_cause ,Microbiology ,Cell Line ,Virology ,Viral structural protein ,medicine ,Animals ,Humans ,Replicon ,Virus Assembly ,Structure and Assembly ,Genetic Complementation Test ,Dengue Virus ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,Flavivirus ,Virion assembly ,Insect Science ,Viral replication complex ,RNA, Viral - Abstract
Flavivirus nonstructural protein 2A (NS2A) plays important roles in both viral RNA synthesis and virion assembly. The molecular details of how the NS2A protein modulates the two distinct events have not been defined. To address this question, we have performed a systematic mutagenesis of NS2A using dengue virus (DENV) serotype 2 (DENV-2) as a model. We identified two sets of NS2A mutations with distinct defects during a viral infection cycle. One set of NS2A mutations (D125A and G200A) selectively abolished viral RNA synthesis. Mechanistically, the D125A mutation abolished viral RNA synthesis through blocking the N-terminal cleavage of the NS2A protein, leading to an unprocessed NS1-NS2A protein; this result suggests that amino acid D125 (far downstream of the N terminus of NS2A) may contribute to the recognition of host protease at the NS1-NS2A junction. The other set of NS2A mutations (G11A, E20A, E100A, Q187A, and K188A) specifically impaired virion assembly without significantly affecting viral RNA synthesis. Remarkably, mutants defective in virion assembly could be rescued by supplying in trans wild-type NS2A molecules expressed from a replicative replicon, by wild-type NS2A protein expressed alone, by a mutant NS2A (G200A) that is lethal for viral RNA synthesis, or by a different mutant NS2A that is defective in virion assembly. In contrast, none of the mutants defective in viral RNA synthesis could be rescued by trans -complementation. Collectively, the results indicate that two distinct sets of NS2A molecules are responsible for DENV RNA synthesis and virion assembly. IMPORTANCE Dengue virus (DENV) represents the most prevalent mosquito-borne human pathogen. Understanding the replication of DENV is essential for development of vaccines and therapeutics. Here we characterized the function of DENV-2 NS2A using a systematic mutagenesis approach. The mutagenesis results revealed two distinct sets of NS2A mutations: one set of mutations that result in defects in viral RNA synthesis and another set of mutations that result in defects in virion assembly. trans -Complementation analysis showed that mutants defective in viral RNA synthesis could not be rescued by wild-type NS2A; in contrast, mutants defective in virion assembly could be successfully rescued by wild-type NS2A or even by a mutant NS2A that is incompetent to support viral RNA synthesis. These results support a model in which two distinct sets of NS2A molecules are responsible for DENV RNA synthesis (located in the viral replication complex) and virion assembly (located in the virion assembly/budding site). The study confirms and extends our understanding of the two critical roles of flavivirus NS2A in viral RNA synthesis and virion assembly.
- Published
- 2015
21. West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5
- Author
-
Hong Lei Zhang, Bo Zhang, Han-Qing Ye, Si Qing Liu, Cheng Lin Deng, Pei Yong Shi, and Xiao-Dan Li
- Subjects
0301 basic medicine ,Proteasome Endopeptidase Complex ,Interferon-Induced Helicase, IFIH1 ,viruses ,Immunology ,Viral Nonstructural Proteins ,Microbiology ,Virus ,Cell Line ,03 medical and health sciences ,Interferon ,Virology ,medicine ,Animals ,Humans ,Receptors, Immunologic ,Immune Evasion ,030102 biochemistry & molecular biology ,biology ,RIG-I ,virus diseases ,MDA5 ,Interferon-beta ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,Flavivirus ,030104 developmental biology ,Interferon-beta production ,Insect Science ,Host-Pathogen Interactions ,Proteolysis ,Pathogenesis and Immunity ,DEAD Box Protein 58 ,IRF3 ,West Nile virus ,Interferon regulatory factors ,medicine.drug - Abstract
West Nile virus (WNV) is a mosquito-borne flavivirus that causes epidemics of encephalitis and viscerotropic disease worldwide. This virus has spread rapidly and has posed a significant public health threat since the outbreak in New York City in 1999. The interferon (IFN)-mediated antiviral response represents an important component of virus-host interactions and plays an essential role in regulating viral replication. Previous studies have suggested that multifunctional nonstructural proteins encoded by flaviviruses antagonize the host IFN response via various means in order to establish efficient viral replication. In this study, we demonstrated that the nonstructural protein 1 (NS1) of WNV antagonizes IFN-β production, most likely through suppression of retinoic acid-inducible gene I (RIG-I)-like receptor (RLR) activation. In a dual-luciferase reporter assay, WNV NS1 significantly inhibited the activation of the IFN-β promoter after Sendai virus infection or poly(I·C) treatment. NS1 also suppressed the activation of the IFN-β promoter when it was stimulated by interferon regulatory factor 3 (IRF3)/5D or its upstream molecules in the RLR signaling pathway. Furthermore, NS1 blocked the phosphorylation and nuclear translocation of IRF3 upon stimulation by various inducers. Mechanistically, WNV NS1 targets RIG-I and melanoma differentiation-associated gene 5 (MDA5) by interacting with them and subsequently causing their degradation by the proteasome. Furthermore, WNV NS1 inhibits the K63-linked polyubiquitination of RIG-I, thereby inhibiting the activation of downstream sensors in the RLR signaling pathway. Taken together, our results reveal a novel mechanism by which WNV NS1 interferes with the host antiviral response. IMPORTANCE WNV Nile virus (WNV) has received increased attention since its introduction to the United States. However, the pathogenesis of this virus is poorly understood. This study demonstrated that the nonstructural protein 1 (NS1) of WNV antagonizes the induction of interferon beta (IFN-β) by interacting with and degrading retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5), which are crucial viral sensors in the host innate immune system. Further experiments suggested that NS1-mediated inhibition of the RIG-I-like receptor (RLR) signaling pathway involves inhibition of RIG-I K63-linked polyubiquitination and that the proteasome plays a role in RIG-I degradation. This study provides new insights into the regulation of WNV NS1 in the RLR signaling pathway and reveals a novel mechanism by which WNV evades the host innate immune response. The novel findings may guide us to discover new therapeutic targets and develop effective vaccines for WNV infections.
- Published
- 2017
22. Understanding Zika Virus stability and developing a chimeric vaccine through functional analysis
- Author
-
Pedro Fernando da Costa Vasconcelos, Chao Shan, Shannan L. Rossi, Pei Yong Shi, Yujiao Yang, Antonio E. Muruato, Xuping Xie, Bruno Tardelli Diniz Nunes, Daniele Barbosa de Almeida Medeiros, Jing Zou, and Scott C. Weaver
- Subjects
0301 basic medicine ,viruses ,DNA Mutational Analysis ,Dengue virus ,Virus Replication ,medicine.disease_cause ,Dengue ,Mice ,Virul?ncia ,Temperatura Ambiente ,Viral Envelope Proteins ,Interferon ,Neutralizing antibody ,Sequence Deletion ,Recombination, Genetic ,Virulence ,biology ,Zika Virus Infection ,Temperature ,virus diseases ,QR1-502 ,3. Good health ,Flavivirus ,Microscopia de Fluoresc?ncia / m?todos ,Rea??o em Cadeia da Polimerase Via Transcriptase Reversa / m?todos ,V?rus da Dengue / imunologia ,Substitui??o de Amino?cidos ,Research Article ,medicine.drug ,V?rus da Dengue / efeitos de radia??o ,Replica??o Viral / efeitos de radia??o ,Context (language use) ,Vaccines, Attenuated ,Microbiology ,Virus ,03 medical and health sciences ,Zika virus / imunologia ,Viral envelope ,Virology ,medicine ,V?rus da Dengue / fisiologia ,Animals ,Zika virus / efeitos de radia??o ,Viral Vaccines ,Zika Virus ,Dengue Virus ,biology.organism_classification ,Zika virus / gen?tica ,An?lise Mutacional de DNA ,Disease Models, Animal ,030104 developmental biology ,Amino Acid Substitution ,Viral replication ,Prote?nas do Envelope Viral / gen?tica ,biology.protein ,V?rus da Dengue / gen?tica ,Vacinas Atenuadas ,Recombina??o Gen?tica ,Zika virus / fisiologia - Abstract
Compared with other flaviviruses, Zika virus (ZIKV) is uniquely associated with congenital diseases in pregnant women. One recent study reported that (i) ZIKV has higher thermostability than dengue virus (DENV [a flavivirus closely related to ZIKV]), which might contribute to the disease outcome; (ii) the higher thermostability of ZIKV could arise from an extended loop structure in domain III of the viral envelope (E) protein and an extra hydrogen-bond interaction between E molecules (V. A. Kostyuchenko, E. X. Y. Lim, S. Zhang, G. Fibriansah, T.-S. Ng, J. S. G. Ooi, J. Shi, and S.-M. Lok, Nature 533:425–428, 2016, https://doi.org/10.1038/nature17994). Here we report the functional analysis of the structural information in the context of complete ZIKV and DENV-2 virions. Swapping the prM-E genes between ZIKV and DENV-2 switched the thermostability of the chimeric viruses, identifying the prM-E proteins as the major determinants for virion thermostability. Shortening the extended loop of the E protein by 1 amino acid was lethal for ZIKV assembly/release. Mutations (Q350I and T351V) that abolished the extra hydrogen-bond interaction between the E proteins did not reduce ZIKV thermostability, indicating that the extra interaction does not increase the thermostability. Interestingly, mutant T351V was attenuated in A129 mice defective in type I interferon receptors, even though the virus retained the wild-type thermostability. Furthermore, we found that a chimeric ZIKV with the DENV-2 prM-E and a chimeric DENV-2 with the ZIKV prM-E were highly attenuated in A129 mice; these chimeric viruses were highly immunogenic and protective against DENV-2 and ZIKV challenge, respectively. These results indicate the potential of these chimeric viruses for vaccine development., IMPORTANCE Analysis of a recently observed high-resolution structure of ZIKV led to a hypothesis that its unusual stability may contribute to the associated, unique disease outcomes. Here we performed a functional analysis to demonstrate that viral prM-E genes are the main determinants for the high stability of ZIKV. The extra hydrogen-bond interaction (observed in the high-resolution structure) between ZIKV E proteins did not enhance virion stability, whereas the extended loop of E protein (CD loop in domain III) was essential for ZIKV assembly. More importantly, we found that a chimeric ZIKV with DENV-2 prM-E genes and a chimeric DENV-2 with ZIKV prM-E genes were highly attenuated in A129 mice. Mice immunized with these chimeric viruses generated robust neutralizing antibody responses and were fully protected from DENV-2 and ZIKV challenge, respectively, indicating that these chimeric viruses could be further developed as vaccine candidates.
- Published
- 2017
23. Dimerization of Flavivirus NS4B Protein
- Author
-
CongBao Kang, Julien Lescar, Le Tian Lee, Zhiming Yuan, Pei Yong Shi, Aline Reynaud, Ramya Chandrasekaran, Lijian Yap, Qing Yin Wang, Xuping Xie, Hongping Dong, Jing Zou, and School of Biological Sciences
- Subjects
viruses ,Amino Acid Motifs ,Immunology ,Mutagenesis (molecular biology technique) ,Viral Nonstructural Proteins ,Biology ,Dengue virus ,medicine.disease_cause ,Microbiology ,Dengue ,Replication factor C ,Virology ,medicine ,Humans ,Replicon ,Endoplasmic reticulum ,RNA ,Dengue Virus ,Genome Replication and Regulation of Viral Gene Expression ,Science::Biological sciences [DRNTU] ,Membrane protein ,Biochemistry ,Viral replication ,Insect Science ,Dimerization ,West Nile virus ,West Nile Fever - Abstract
Flavivirus replication is mediated by a complex machinery that consists of viral enzymes, nonenzymatic viral proteins, and host factors. Many of the nonenzymatic viral proteins, such as NS4B, are associated with the endoplasmic reticulum membrane. How these membrane proteins function in viral replication is poorly understood. Here we report a robust method to express and purify dengue virus (DENV) and West Nile virus NS4B proteins. The NS4B proteins were expressed in Escherichia coli , reconstituted in dodecyl maltoside (DDM) detergent micelles, and purified to >95% homogeneity. The recombinant NS4B proteins dimerized in vitro , as evidenced by gel filtration, chemical cross-linking, and multiangle light scattering experiments. The dimeric form of NS4B was also detected when the protein was expressed alone in cells as well as in cells infected with DENV type 2 (DENV-2). Mutagenesis analysis showed that the cytosolic loop (amino acids 129 to 165) and the C-terminal region (amino acids 166 to 248) are responsible for NS4B dimerization. trans -Complementation experiments showed that (i) two genome-length RNAs containing distinct NS4B lethal mutations could not trans -complement each other, (ii) the replication defect of NS4B mutant RNA could be restored in cells containing DENV-2 replicons, and (iii) expression of wild-type NS4B protein alone was not sufficient to restore the replication of the NS4B mutant RNA. Collectively, the results indicate that trans -complementation of a lethal NS4B mutant RNA requires wild-type NS4B presented from a replication complex. IMPORTANCE The reported expression and purification system has made it possible to study the biochemistry and structure of flavivirus NS4B proteins. The finding of flavivirus NS4B dimerization and the mapping of regions important for NS4B dimerization provide the possibility to inhibit viral replication through blocking NS4B dimerization. The requirement of NS4B in the context of the replication complex for successful trans -complementation enhances our understanding of NS4B in flavivirus replication.
- Published
- 2014
24. Rational Design of a Flavivirus Vaccine by Abolishing Viral RNA 2′- O Methylation
- Author
-
E-De Qin, Yong-Qiang Deng, Xiaofeng Li, Shihua Li, Cheng-Feng Qin, Qibin Leng, Qing Ye, Hui Zhao, Xiaoyu Wang, Xuping Xie, Shun-Ya Zhu, Hong-Jiang Wang, Bo Zhang, Roland Zuest, Pei Yong Shi, and Hongping Dong
- Subjects
viruses ,Immunology ,Biology ,Antibodies, Viral ,Vaccines, Attenuated ,Recombinant virus ,Methylation ,Microbiology ,Virus ,Mice ,Viral entry ,Interferon ,Virology ,Vaccines and Antiviral Agents ,medicine ,Animals ,Encephalitis, Japanese ,Encephalitis Virus, Japanese ,Mice, Inbred BALB C ,tRNA Methyltransferases ,Attenuated vaccine ,Japanese Encephalitis Vaccines ,RNA ,biology.organism_classification ,Survival Analysis ,TRNA Methyltransferases ,Disease Models, Animal ,Flavivirus ,Insect Science ,Leukocytes, Mononuclear ,RNA, Viral ,Female ,medicine.drug - Abstract
Viruses that replicate in the cytoplasm cannot access the host nuclear capping machinery. These viruses have evolved viral methyltransferase(s) to methylate N-7 and 2′- O cap of their RNA; alternatively, they “snatch” host mRNA cap to form the 5′ end of viral RNA. The function of 2′- O methylation of viral RNA cap is to mimic cellular mRNA and to evade host innate immune restriction. A cytoplasmic virus defective in 2′- O methylation is replicative, but its viral RNA lacks 2′- O methylation and is recognized and eliminated by the host immune response. Such a mutant virus could be rationally designed as a live attenuated vaccine. Here, we use Japanese encephalitis virus (JEV), an important mosquito-borne flavivirus, to prove this novel vaccine concept. We show that JEV methyltransferase is responsible for both N-7 and 2′- O cap methylations as well as evasion of host innate immune response. Recombinant virus completely defective in 2′- O methylation was stable in cell culture after being passaged for >30 days. The mutant virus was attenuated in mice, elicited robust humoral and cellular immune responses, and retained the engineered mutation in vivo . A single dose of immunization induced full protection against lethal challenge with JEV strains in mice. Mechanistically, the attenuation phenotype was attributed to the enhanced sensitivity of the mutant virus to the antiviral effects of interferon and IFIT proteins. Collectively, the results demonstrate the feasibility of using 2′- O methylation-defective virus as a vaccine approach; this vaccine approach should be applicable to other flaviviruses and nonflaviviruses that encode their own viral 2′- O methyltransferases.
- Published
- 2013
25. Membrane Topology and Function of Dengue Virus NS2A Protein
- Author
-
Zhiming Yuan, Xuping Xie, Shovanlal Gayen, CongBao Kang, and Pei Yong Shi
- Subjects
Models, Molecular ,Magnetic Resonance Spectroscopy ,Protein Conformation ,Viral protein ,viruses ,Immunology ,Viral Nonstructural Proteins ,Biology ,Endoplasmic Reticulum ,medicine.disease_cause ,Microbiology ,Cell Line ,Protein structure ,Viral entry ,Cricetinae ,Virology ,Viral structural protein ,medicine ,Animals ,Humans ,chemistry.chemical_classification ,Virus Assembly ,Structure and Assembly ,Intracellular Membranes ,Dengue Virus ,biochemical phenomena, metabolism, and nutrition ,Amino acid ,Biochemistry ,chemistry ,Virion assembly ,Insect Science ,Membrane topology ,Viral replication complex - Abstract
Flavivirus nonstructural protein 2A (NS2A) is a component of the viral replication complex that functions in virion assembly and antagonizes the host immune response. Although flavivirus NS2A is known to associate with the endoplasmic reticulum (ER) membrane, the detailed topology of this protein has not been determined. Here we report the first topology model of flavivirus NS2A on the ER membrane. Using dengue virus (DENV) NS2A as a model, we show that (i) the N-terminal 68 amino acids are located in the ER lumen, with one segment (amino acids 30 to 52) that interacts with ER membrane without traversing the lipid bilayer; (ii) amino acids 69 to 209 form five transmembrane segments, each of which integrally spans the ER membrane; and (iii) the C-terminal tail (amino acids 210 to 218) is located in the cytosol. Nuclear magnetic resonance (NMR) structural analysis showed that the first membrane-spanning segment (amino acids 69 to 93) consists of two helices separated by a “helix breaker.” The helix breaker is formed by amino acid P85 and one positively charged residue, R84. Functional analysis using replicon and genome-length RNAs of DENV-2 indicates that P85 is not important for viral replication. However, when R84 was replaced with E, the mutation attenuated both viral RNA synthesis and virus production. Remarkably, an R84A mutation did not affect viral RNA synthesis but blocked intracellular formation of infectious virions. Collectively, the mutagenesis results demonstrate that NS2A functions in both DENV RNA synthesis and virion assembly/maturation. The topology model of DENV NS2A provides a good starting point for studying how flavivirus NS2A modulates viral replication and evasion of host immune response.
- Published
- 2013
26. Transmembrane Domains of NS2B Contribute to both Viral RNA Replication and Particle Formation in Japanese Encephalitis Virus
- Author
-
Xiao-Dan Li, Hong Lei Zhang, Pan Tao Zhang, Han-Qing Ye, Dong Dong Chen, Pei Yong Shi, Bo Zhang, Cheng Lin Deng, Qiu Yan Zhang, and Zhiming Yuan
- Subjects
0301 basic medicine ,viruses ,Immunology ,DNA Mutational Analysis ,Viral Nonstructural Proteins ,medicine.disease_cause ,Virus Replication ,Microbiology ,Virus ,03 medical and health sciences ,Protein Domains ,Virology ,medicine ,Humans ,Encephalitis Virus, Japanese ,Mutation ,NS3 ,biology ,Virus Assembly ,RNA ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,Genome Replication and Regulation of Viral Gene Expression ,Transmembrane domain ,Flavivirus ,030104 developmental biology ,Viral replication ,Virion assembly ,Mutagenesis ,Insect Science ,RNA, Viral - Abstract
Flavivirus nonstructural protein 2B (NS2B) is a transmembrane protein that functions as a cofactor for viral NS3 protease. The cytoplasmic region (amino acids 51 to 95) alone of NS2B is sufficient for NS3 protease activity, whereas the role of transmembrane domains (TMDs) remains obscure. Here, we demonstrate for the first time that flavivirus NS2B plays a critical role in virion assembly. Using Japanese encephalitis virus (JEV) as a model, we performed a systematic mutagenesis at the flavivirus conserved residues within the TMDs of NS2B. As expected, some mutations severely attenuated (L38A and R101A) or completely destroyed (G12L) viral RNA synthesis. Interestingly, two mutations (G37L and P112A) reduced viral RNA synthesis and blocked virion assembly. None of the mutations affected NS2B-NS3 protease activity. Because mutations G37L and P112A affected virion assembly, we selected revertant viruses for these two mutants. For mutant G37L, replacement with G37F, G37H, G37T, or G37S restored virion assembly. For mutant P112A, insertion of K at position K127 (leading to K127KK) of NS2B rescued virion assembly. A biomolecular fluorescent complementation (BiFC) analysis demonstrated that (i) mutation P112A selectively weakened NS2B-NS2A interaction and (ii) the adaptive mutation K127KK restored NS2B-NS2A interaction. Collectively, our results demonstrate that, in addition to being a cofactor for NS3 protease, flavivirus NS2B also functions in viral RNA replication, as well as virion assembly. IMPORTANCE Many flaviviruses are important human pathogens. Understanding the molecular mechanisms of the viral infection cycle is essential for vaccine and antiviral development. In this study, we demonstrate that the TMDs of JEV NS2B participate in both viral RNA replication and virion assembly. A viral genetic study and a BiFC assay demonstrated that interaction between NS2B and NS2A may participate in modulating viral assembly in the flavivirus life cycle. Compensatory-mutation analysis confirmed that there was a correlation between viral assembly and NS2B-NS2A interaction. TMDs of NS2B may serve as novel antiviral targets to prevent flavivirus infection, and the structure determination of NS2B will help us to understand the functional mechanism of NS2B in viral RNA replication and assembly. The results have uncovered a new function of flavivirus NS2B in virion assembly, possibly through interaction with the NS2A protein.
- Published
- 2016
27. Nonconsensus West Nile Virus Genomes Arising during Mosquito Infection Suppress Pathogenesis and Modulate Virus Fitness In Vivo
- Author
-
Kelly A. Fitzpatrick, Laura D. Kramer, Kristen A. Bernard, Gregory D. Ebel, Pei Yong Shi, Eleanor R. Deardorff, Pei-Yin Lim, Greta V.S. Jerzak, Corey J. Bennett, and Yangsheng Zhou
- Subjects
viruses ,Immunology ,Population ,Genome, Viral ,Viral Nonstructural Proteins ,Biology ,Kidney ,Virus Replication ,medicine.disease_cause ,Microbiology ,Virus ,Mice ,Cricetinae ,Virology ,Chlorocebus aethiops ,medicine ,Animals ,education ,Vero Cells ,Cells, Cultured ,Genetics ,Mice, Inbred C3H ,education.field_of_study ,Mutation ,Serine Endopeptidases ,Genetic Variation ,virus diseases ,RNA ,Fibroblasts ,Type I interferon production ,RNA Helicase A ,Reverse genetics ,Culicidae ,Genetic Diversity and Evolution ,Viral replication ,Insect Science ,RNA, Viral ,Female ,Interferons ,Chickens ,West Nile virus ,RNA Helicases ,West Nile Fever - Abstract
West Nile virus (WNV) is similar to other RNA viruses in that it forms genetically complex populations within hosts. The virus is maintained in nature in mosquitoes and birds, with each host type exerting distinct influences on virus populations. We previously observed that prolonged replication in mosquitoes led to increases in WNV genetic diversity and diminished pathogenesis in mice without remarkable changes to the consensus genome sequence. We therefore sought to evaluate the relationships between individual and group phenotypes in WNV and to discover novel viral determinants of pathogenesis in mice and fitness in mosquitoes and birds. Individual plaque size variants were isolated from a genetically complex population, and mutations conferring a small-plaque and mouse-attenuated phenotype were localized to the RNA helicase domain of the NS3 protein by reverse genetics. The mutation, an Asp deletion, did not alter type I interferon production in the host but rendered mutant viruses more susceptible to interferon compared to wild type (WT) WNV. Finally, we used an in vivo fitness assay in Culex quinquefasciatus mosquitoes and chickens to determine whether the mutation in NS3 influenced fitness. The fitness of the NS3 mutant was dramatically lower in chickens and moderately lower in mosquitoes, indicating that RNA helicase is a major fitness determinant of WNV and that the effect on fitness is host specific. Overall, this work highlights the complex relationships that exist between individual and group phenotypes in RNA viruses and identifies RNA helicase as an attenuation and fitness determinant in WNV.
- Published
- 2011
28. Inhibition of Dengue Virus by Targeting Viral NS4B Protein
- Author
-
Laura D. Kramer, Qing Yin Wang, Hao Ying Xu, Zhiming Yuan, Min Qing, Xuping Xie, and Pei Yong Shi
- Subjects
Virulence Factors ,viruses ,DNA Mutational Analysis ,Immunology ,Drug Evaluation, Preclinical ,Microbial Sensitivity Tests ,Viral Nonstructural Proteins ,Dengue virus ,Biology ,medicine.disease_cause ,Antiviral Agents ,Microbiology ,Virus ,Cell Line ,Viral entry ,Virology ,Vaccines and Antiviral Agents ,Drug Resistance, Viral ,medicine ,Viral structural protein ,Animals ,Humans ,Replicon ,Mutation ,virus diseases ,Dengue Virus ,biochemical phenomena, metabolism, and nutrition ,Resistance mutation ,biology.organism_classification ,Molecular biology ,Vesicular stomatitis virus ,Insect Science ,RNA, Viral - Abstract
We report a novel inhibitor that selectively suppresses dengue virus (DENV) by targeting viral NS4B protein. The inhibitor was identified by screening a 1.8-million-compound library using a luciferase replicon of DENV serotype 2 (DENV-2). The compound specifically inhibits all four serotypes of DENV (50% effective concentration [EC 50 ], 1 to 4 μM; and 50% cytotoxic concentration [CC 50 ], >40 μM), but it does not inhibit closely related flaviviruses (West Nile virus and yellow fever virus) or nonflaviviruses (Western equine encephalomyelitis virus, Chikungunya virus, and vesicular stomatitis virus). A mode-of-action study suggested that the compound inhibits viral RNA synthesis. Replicons resistant to the inhibitor were selected in cell culture. Sequencing of the resistant replicons revealed two mutations (P104L and A119T) in the viral NS4B protein. Genetic analysis, using DENV-2 replicon and recombinant viruses, demonstrated that each of the two NS4B mutations alone confers partial resistance and double mutations confer additive resistance to the inhibitor in mammalian cells. In addition, we found that a replication defect caused by a lethal NS4B mutation could be partially rescued through trans complementation. The ability to complement NS4B in trans affected drug sensitivity when a single cell was coinfected with drug-sensitive and drug-resistant viruses. Mechanistically, NS4B was previously shown to interact with the viral NS3 helicase domain; one of the two NS4B mutations recovered in our resistance analysis—P104L—abolished the NS3-NS4B interaction (I. Umareddy, A. Chao, A. Sampath, F. Gu, and S. G. Vasudevan, J. Gen. Virol. 87:2605-2614, 2006). Collectively, the results suggest that the identified inhibitor targets the DENV NS4B protein, leading to a defect in viral RNA synthesis.
- Published
- 2011
29. Keratinocytes Are Cell Targets of West Nile Virus In Vivo
- Author
-
Melissa Behr, Kristen A. Bernard, Pei Yong Shi, Chrystal M. Chadwick, and Pei Yin Lim
- Subjects
Keratinocytes ,animal diseases ,viruses ,Immunology ,Cell ,Biology ,Microbiology ,Virus ,Mice ,In vivo ,Virology ,Keratin ,medicine ,Animals ,Replicon ,Skin ,chemistry.chemical_classification ,Mice, Inbred C3H ,Microscopy ,integumentary system ,Epidermis (botany) ,virus diseases ,Keratin-10 ,biology.organism_classification ,Immunohistochemistry ,nervous system diseases ,Mice, Inbred C57BL ,Flavivirus ,medicine.anatomical_structure ,chemistry ,Insect Science ,Pathogenesis and Immunity ,Female ,Keratinocyte ,West Nile virus ,West Nile Fever - Abstract
West Nile virus (WNV) replicates in the skin; however, cell targets in the skin have not been identified. In the current studies, WNV infected the epidermis and adnexal glands of mouse skin, and the epidermal cells were identified as keratinocytes by double labeling for WNV antigen and keratin 10. Inoculation of mice with WNV replicon particles resulted in high levels of replication in the skin, suggesting that keratinocytes are an initial target of WNV. In addition, primary keratinocytes produced infectious virus in vitro . In conclusion, keratinocytes are cell targets of WNV in vivo and may play an important role in pathogenesis.
- Published
- 2011
30. The 5′ and 3′ Downstream AUG Region Elements Are Required for Mosquito-Borne Flavivirus RNA Replication
- Author
-
Peter Friebe, Eva Harris, and Pei Yong Shi
- Subjects
viruses ,Molecular Sequence Data ,Immunology ,Biology ,Dengue virus ,Virus Replication ,medicine.disease_cause ,Microbiology ,Genome ,Virus ,Virology ,parasitic diseases ,medicine ,Animals ,Humans ,Replicon ,3' Untranslated Regions ,Genetics ,Base Sequence ,Three prime untranslated region ,Flavivirus ,fungi ,biology.organism_classification ,Genome Replication and Regulation of Viral Gene Expression ,Culicidae ,Viral replication ,Insect Science ,Complementarity (molecular biology) ,Mutation ,RNA, Viral ,5' Untranslated Regions ,West Nile virus - Abstract
Flaviviruses require complementarity between the 5′ and 3′ ends of the genome for RNA replication. For mosquito-borne flaviviruses, the cyclization sequences (CS) and upstream of AUG region (UAR) elements at the genomic termini are necessary for viral RNA replication, and a third motif, the downstream of AUG region (DAR), was recently designated for dengue virus. The 3′ DAR sequence is also part of a hairpin (HP-3′SL), and both complementarity between 5′ and 3′ DAR motifs and formation of the HP-3′SL in the absence of the 5′ end are conserved among mosquito-borne flaviviruses. Using West Nile virus as a model, we demonstrate that 5′-3′ DAR complementarity and HP-3′SL formation are essential for viral RNA replication.
- Published
- 2011
31. RNA Structures Required for Production of Subgenomic Flavivirus RNA
- Author
-
Ezequiel Balmori Melian, Hongping Dong, Alexander A. Khromykh, Judy Edmonds, Nadia Floden, Tomoko Nagasaki, Katherine Truong, Shessy Torres, Pei Yong Shi, and Anneke Funk
- Subjects
Untranslated region ,Immunology ,Microbiology ,Mice ,Kunjin virus ,Virology ,Exoribonuclease ,Animals ,Guide RNA ,3' Untranslated Regions ,Subgenomic mRNA ,Genetics ,biology ,Flavivirus ,RNA ,biology.organism_classification ,Non-coding RNA ,Genome Replication and Regulation of Viral Gene Expression ,DNA-Binding Proteins ,Insect Science ,Exoribonucleases ,Nucleic Acid Conformation ,RNA, Viral ,Pseudoknot ,West Nile virus - Abstract
Flaviviruses are a group of single-stranded, positive-sense RNA viruses causing ∼100 million infections per year. We have recently shown that flaviviruses produce a unique, small, noncoding RNA (∼0.5 kb) derived from the 3′ untranslated region (UTR) of the genomic RNA (gRNA), which is required for flavivirus-induced cytopathicity and pathogenicity (G. P. Pijlman et al., Cell Host Microbe, 4: 579-591, 2008). This RNA (subgenomic flavivirus RNA [sfRNA]) is a product of incomplete degradation of gRNA presumably by the cellular 5′-3′ exoribonuclease XRN1, which stalls on the rigid secondary structure stem-loop II (SL-II) located at the beginning of the 3′ UTR. Mutations or deletions of various secondary structures in the 3′ UTR resulted in the loss of full-length sfRNA (sfRNA1) and production of smaller and less abundant sfRNAs (sfRNA2 and sfRNA3). Here, we investigated in detail the importance of West Nile virus Kunjin (WNV KUN ) 3′ UTR secondary structures as well as tertiary interactions for sfRNA formation. We show that secondary structures SL-IV and dumbbell 1 (DB1) downstream of SL-II are able to prevent further degradation of gRNA when the SL-II structure is deleted, leading to production of sfRNA2 and sfRNA3, respectively. We also show that a number of pseudoknot (PK) interactions, in particular PK1 stabilizing SL-II and PK3 stabilizing DB1, are required for protection of gRNA from nuclease degradation and production of sfRNA. Our results show that PK interactions play a vital role in the production of nuclease-resistant sfRNA, which is essential for viral cytopathicity in cells and pathogenicity in mice.
- Published
- 2010
32. Characterization of Dengue Virus Resistance to Brequinar in Cell Culture
- Author
-
Zhiming Yuan, Hao Ying Xu, Gang Zou, Hongping Dong, Qing Yin Wang, Min Qing, and Pei Yong Shi
- Subjects
viruses ,Alphavirus ,Dengue virus ,medicine.disease_cause ,Antiviral Agents ,Virus ,Chlorocebus aethiops ,Drug Resistance, Viral ,medicine ,Animals ,Pharmacology (medical) ,Vero Cells ,Polymerase ,Pharmacology ,biology ,Biphenyl Compounds ,RNA ,Dengue Virus ,biology.organism_classification ,Virology ,Molecular biology ,Flavivirus ,Pyrimidines ,Infectious Diseases ,Vesicular stomatitis virus ,Virion assembly ,biology.protein ,RNA, Viral - Abstract
Brequinar is an inhibitor of dihydroorotate dehydrogenase, an enzyme that is required for de novo pyrimidine biosynthesis. Here we report that brequinar has activity against a broad spectrum of viruses. The compound not only inhibits flaviviruses (dengue virus, West Nile virus, yellow fever virus, and Powassan virus) but also suppresses a plus-strand RNA alphavirus (Western equine encephalitis virus) and a negative-strand RNA rhabdovirus (vesicular stomatitis virus). Using dengue virus serotype 2 (DENV-2) as a model, we found that brequinar suppressed the viral infection cycle mainly at the step of RNA synthesis. Supplementing the culture medium with pyrimidines (cytidine or uridine) but not purines (adenine or guanine) could be used to reverse the inhibitory effect of the compound. Continuous culturing of DENV-2 in the presence of brequinar generated viruses that were partially resistant to the inhibitor. Sequencing of the resistant viruses revealed two amino acid mutations: one mutation (M260V) located at a helix in the domain II of the viral envelope protein and another mutation (E802Q) located at the priming loop of the nonstructural protein 5 (NS5) polymerase domain. Functional analysis of the mutations suggests that the NS5 mutation exerts resistance through enhancement of polymerase activity. The envelope protein mutation reduced the efficiency of virion assembly/release; however, the mutant virus became less sensitive to brequinar inhibition at the step of virion assembly/release. Taken together, the results indicate that (i) brequinar blocks DENV RNA synthesis through depletion of intracellular pyrimidine pools and (ii) the compound may also exert its antiviral activity through inhibition of virion assembly/release.
- Published
- 2010
33. Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections
- Author
-
Jinhong Chang, Dong Jiang, Min Qing, Ju-Tao Guo, Timothy M. Block, Chunxiao Xu, Xianchao Zhang, Alex V. Birk, Pei Yong Shi, Xiao-Ben Pan, Jessica M. Weidner, and Haitao Guo
- Subjects
Exonucleases ,Oxidoreductases Acting on CH-CH Group Donors ,viruses ,Immunology ,Alpha interferon ,Biology ,Dengue virus ,Virus Replication ,medicine.disease_cause ,Microbiology ,Virus ,Cell Line ,Dengue fever ,eIF-2 Kinase ,Interferon ,Virology ,medicine ,Humans ,Interferon-alpha ,Membrane Proteins ,Proteins ,RNA-Binding Proteins ,virus diseases ,Dengue Virus ,Virus Internalization ,medicine.disease ,biology.organism_classification ,Virus-Cell Interactions ,Flavivirus ,Gene Expression Regulation ,Viral replication ,Insect Science ,Viperin ,Exoribonucleases ,Host-Pathogen Interactions ,West Nile virus ,medicine.drug - Abstract
Interferons (IFNs) are key mediators of the host innate antiviral immune response. To identify IFN-stimulated genes (ISGs) that instigate an antiviral state against two medically important flaviviruses, West Nile virus (WNV) and dengue virus (DENV), we tested 36 ISGs that are commonly induced by IFN-α for antiviral activity against the two viruses. We discovered that five ISGs efficiently suppressed WNV and/or DENV infection when they were individually expressed in HEK293 cells. Mechanistic analyses revealed that two structurally related cell plasma membrane proteins, IFITM2 and IFITM3, disrupted early steps (entry and/or uncoating) of the viral infection. In contrast, three IFN-induced cellular enzymes, viperin, ISG20, and double-stranded-RNA-activated protein kinase, inhibited steps in viral proteins and/or RNA biosynthesis. Our results thus imply that the antiviral activity of IFN-α is collectively mediated by a panel of ISGs that disrupt multiple steps of the DENV and WNV life cycles.
- Published
- 2010
34. Inhibition of Dengue Virus by an Ester Prodrug of an Adenosine Analog
- Author
-
Suresh B. Lakshminarayana, Andy Yip, Anne Goh, Margaret Weaver, Wouter Schul, Boping Liu, Yen Liang Chen, Hao Ying Xu, Min Qing, Véronique Dartois, Thomas H. Keller, Pei Yong Shi, Zheng Yin, Jeyaraj Duraiswamy, and Ravinder Reddi Kondreddi
- Subjects
Adenosine ,viruses ,Hepatitis C virus ,Alphavirus ,Dengue virus ,Virus Replication ,medicine.disease_cause ,Antiviral Agents ,Virus ,Cell Line ,Dengue ,Mice ,In vivo ,Cell Line, Tumor ,Chlorocebus aethiops ,medicine ,Animals ,Humans ,Prodrugs ,Pharmacology (medical) ,Vero Cells ,Pharmacology ,biology ,virus diseases ,Epithelial Cells ,Esters ,biochemical phenomena, metabolism, and nutrition ,Dengue Virus ,Prodrug ,biology.organism_classification ,Virology ,Rats ,Flavivirus ,Infectious Diseases ,Nucleoside - Abstract
Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen that infects humans. Neither a vaccine nor an antiviral therapy is currently available for DENV. Here, we report an adenosine nucleoside prodrug that potently inhibits DENV replication both in cell culture and in a DENV mouse model. NITD449 (2′- C -acetylene-7-deaza-7-carbamoyladenosine) was initially identified as a parental compound that inhibits all four serotypes of DENV with low cytotoxicity. However, in vivo pharmacokinetic studies indicated that NITD449 had a low level of exposure in plasma when dosed orally. To increase the oral bioavailability, we covalently linked isobutyric acids to the 3′- and 5′-hydroxyl groups of ribose via ester linkage to NITD449, leading to the prodrug NITD203 (3′,5′- O -diisobutyryl-2′- C -acetylene-7-deaza-7-carbamoyl-adenosin). Pharmacokinetic analysis showed that upon oral dosing of the prodrug, NITD203 was readily converted to NITD449, resulting in improved exposure of the parental compound in plasma in both mouse and rat. In DENV-infected AG129 mice, oral dosing of the prodrug at 25 mg/kg of body weight reduced peak viremia by 30-fold. Antiviral spectrum analysis showed that NITD203 inhibited various flaviviruses (DENV, yellow fever virus, and West Nile virus) and hepatitis C virus but not Chikungunya virus (an alphavirus). Mode-of-action analysis, using a luciferase-reporting replicon, indicated that NITD203 inhibited DENV RNA synthesis. Although NITD203 exhibited potent in vitro and in vivo efficacies, the compound could not reach a satisfactory no-observable-adverse-effect level (NOAEL) in a 2-week in vivo toxicity study. Nevertheless, our results demonstrate that a prodrug approach using a nucleoside analog could potentially be developed for flavivirus antiviral therapy.
- Published
- 2010
35. Inhibition of Dengue Virus Polymerase by Blocking of the RNA Tunnel
- Author
-
Dieter Mueller, Pornwaratt Niyomrattanakit, J. Frasier Glickman, Hongping Dong, Min Qing, Zheng Yin, Thomas H. Keller, Hans Voshol, Kai Lin, Joanne Y.H. Lim, Shahul Nilar, Pei Yong Shi, and Yen Liang Chen
- Subjects
viruses ,Hepatitis C virus ,Immunology ,Drug Evaluation, Preclinical ,Dengue virus ,Biology ,medicine.disease_cause ,Antiviral Agents ,Microbiology ,Primer extension ,Dengue ,Inhibitory Concentration 50 ,chemistry.chemical_compound ,Virology ,RNA polymerase ,medicine ,Animals ,ortho-Aminobenzoates ,Binding site ,Polymerase ,Subgenomic mRNA ,Binding Sites ,virus diseases ,RNA ,Dengue Virus ,RNA-Dependent RNA Polymerase ,Sulfinic Acids ,Molecular biology ,Genome Replication and Regulation of Viral Gene Expression ,chemistry ,Insect Science ,biology.protein ,RNA, Viral ,Allosteric Site - Abstract
Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen in humans. Neither vaccine nor antiviral therapy is currently available for DENV. We report here that N -sulfonylanthranilic acid derivatives are allosteric inhibitors of DENV RNA-dependent RNA polymerase (RdRp). The inhibitor was identified through high-throughput screening of one million compounds using a primer extension-based RdRp assay [substrate poly(C)/oligo(G) 20 ]. Chemical modification of the initial “hit” improved the compound potency to an IC 50 (that is, a concentration that inhibits 50% RdRp activity) of 0.7 μM. In addition to suppressing the primer extension-based RNA elongation, the compound also inhibited de novo RNA synthesis using a DENV subgenomic RNA, but at a lower potency (IC 50 of 5 μM). Remarkably, the observed anti-polymerase activity is specific to DENV RdRp; the compound did not inhibit WNV RdRp and exhibited IC 50 s of >100 μM against hepatitis C virus RdRp and human DNA polymerase α and β. UV cross-linking and mass spectrometric analysis showed that a photoreactive inhibitor could be cross-linked to Met343 within the RdRp domain of DENV NS5. On the crystal structure of DENV RdRp, Met343 is located at the entrance of RNA template tunnel. Biochemical experiments showed that the order of addition of RNA template and inhibitor during the assembly of RdRp reaction affected compound potency. Collectively, the results indicate that the compound inhibits RdRp through blocking the RNA tunnel. This study has provided direct evidence to support the hypothesis that allosteric pockets from flavivirus RdRp could be targeted for antiviral development.
- Published
- 2010
36. Exclusion of West Nile Virus Superinfection through RNA Replication
- Author
-
Bo Zhang, Zhiming Yuan, Kristen A. Bernard, Gang Zou, Pei Yin Lim, and Pei Yong Shi
- Subjects
Genes, Viral ,viruses ,Immunology ,Virus Attachment ,Biology ,Superinfection exclusion ,Virus Replication ,medicine.disease_cause ,Microbiology ,Virus ,Cell Line ,Cricetinae ,Virology ,Chlorocebus aethiops ,medicine ,Animals ,Replicon ,Vero Cells ,Gene ,Reverse Transcriptase Polymerase Chain Reaction ,virus diseases ,RNA ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,Genome Replication and Regulation of Viral Gene Expression ,Flavivirus ,Viral replication ,Superinfection ,Insect Science ,RNA, Viral ,West Nile virus - Abstract
Superinfection exclusion is the ability of an established viral infection to interfere with a second viral infection. Using West Nile virus (WNV) as a model, we show that replicating replicons in BHK-21 cells suppress subsequent WNV infection. The WNV replicon also suppresses superinfections of other flaviviruses but not nonflaviviruses. Mode-of-action analysis indicates that the exclusion of WNV superinfection occurs at the step of RNA synthesis. The continuous culturing of WNV in the replicon-containing cells generated variants that could overcome the superinfection exclusion. The sequencing of the selected viruses revealed mutations in structural (prM S90R or envelope E138K) and nonstructural genes (NS4a K124R and peptide 2K V9M). Mutagenesis analysis showed that the mutations in structural genes nonselectively enhance viral infection in both naïve and replicon-containing BHK-21 cells; in contrast, the mutations in nonstructural genes more selectively enhance viral replication in the replicon-containing cells than in the naïve cells. Mechanistic analysis showed that the envelope mutation functions through the enhancement of virion attachment to BHK-21 cells, whereas the 2K mutation (and, to a lesser extent, the NS4a mutation) functions through the enhancement of viral RNA synthesis. Furthermore, we show that WNV superinfection exclusion is reversible by the treatment of the replicon cells with a flavivirus inhibitor. The preestablished replication of the replicon could be suppressed by infecting the cells with the 2K mutant WNV but not with the wild-type virus. These results suggest that WNV superinfection exclusion is a result of competition for intracellular host factors that are required for viral RNA synthesis.
- Published
- 2009
37. Interaction between the Cellular Protein eEF1A and the 3′-Terminal Stem-Loop of West Nile Virus Genomic RNA Facilitates Viral Minus-Strand RNA Synthesis
- Author
-
William G. Davis, Pei Yong Shi, Jerry L. Blackwell, and Margo A. Brinton
- Subjects
RNase P ,viruses ,Immunology ,RNA-dependent RNA polymerase ,Genome, Viral ,Biology ,Virus Replication ,Microbiology ,Cell Line ,Encephalitis Viruses, Tick-Borne ,Viral Proteins ,Peptide Elongation Factor 1 ,Cricetinae ,Virology ,Protein biosynthesis ,Animals ,RNA, Antisense ,Binding site ,3' Untranslated Regions ,RNA ,Stem-loop ,Non-coding RNA ,Molecular biology ,Genome Replication and Regulation of Viral Gene Expression ,Viral replication ,Protein Biosynthesis ,Insect Science ,Mutation ,Nucleic Acid Conformation ,RNA, Viral ,West Nile virus - Abstract
RNase footprinting and nitrocellulose filter binding assays were previously used to map one major and two minor binding sites for the cell protein eEF1A on the 3′(+) stem-loop (SL) RNA of West Nile virus (WNV) (3). Base substitutions in the major eEF1A binding site or adjacent areas of the 3′(+) SL were engineered into a WNV infectious clone. Mutations that decreased, as well as ones that increased, eEF1A binding in in vitro assays had a negative effect on viral growth. None of these mutations affected the efficiency of translation of the viral polyprotein from the genomic RNA, but all of the mutations that decreased in vitro eEF1A binding to the 3′ SL RNA also decreased viral minus-strand RNA synthesis in transfected cells. Also, a mutation that increased the efficiency of eEF1A binding to the 3′ SL RNA increased minus-strand RNA synthesis in transfected cells, which resulted in decreased synthesis of genomic RNA. These results strongly suggest that the interaction between eEF1A and the WNV 3′ SL facilitates viral minus-strand synthesis. eEF1A colocalized with viral replication complexes (RC) in infected cells and antibody to eEF1A coimmunoprecipitated viral RC proteins, suggesting that eEF1A facilitates an interaction between the 3′ end of the genome and the RC. eEF1A bound with similar efficiencies to the 3′-terminal SL RNAs of four divergent flaviviruses, including a tick-borne flavivirus, and colocalized with dengue virus RC in infected cells. These results suggest that eEF1A plays a similar role in RNA replication for all flaviviruses.
- Published
- 2007
38. Synergistic Suppression of Dengue Virus Replication Using a Combination of Nucleoside Analogs and Nucleoside Synthesis Inhibitors
- Author
-
Qing Yin Wang, Yen Liang Chen, Hao Ying Xu, K.L. Yeo, Hongping Dong, Pei Yong Shi, and Fumiaki Yokokawa
- Subjects
Interferon Inducers ,viruses ,Guanosine ,Dengue virus ,Biology ,medicine.disease_cause ,Virus Replication ,Antiviral Agents ,Cell Line ,chemistry.chemical_compound ,Interferon ,Ribavirin ,medicine ,Humans ,Pharmacology (medical) ,Pharmacology ,Interferon inducer ,Nucleoside analogue ,virus diseases ,Drug Synergism ,Nucleosides ,Interferon-beta ,biochemical phenomena, metabolism, and nutrition ,Dengue Virus ,Virology ,Drug Combinations ,Infectious Diseases ,HEK293 Cells ,chemistry ,Pyrimidine metabolism ,Oxidoreductases ,Nucleoside ,medicine.drug - Abstract
Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen in humans. Currently, there is no clinically approved vaccine or antiviral for DENV. Combination therapy is a common practice in antiviral treatment and a potential approach to search for new treatments for infectious pathogens. In this study, we performed a combination treatment in cell culture by using three distinct classes of inhibitors, including ribavirin (a guanosine analog with several antiviral mechanisms), brequinar (a pyrimidine biosynthesis inhibitor), and INX-08189 (a guanosine analog). The compound pairs were evaluated for antiviral activity by use of a DENV-2 luciferase replicon assay. Our result indicated that the combination of ribavirin and INX-08189 exhibited strong antiviral synergy. This result suggests that synergy can be achieved with compound pairs in which one compound suppresses the synthesis of the nucleoside for which the other compound is a corresponding nucleoside analog. In addition, we found that treatment of cells with brequinar alone could activate interferon-stimulated response elements (ISREs); furthermore, brequinar and NITD-982 (another pyrimidine biosynthesis inhibitor) potentiated interferon-induced ISRE activation. Compared to treatment with brequinar, treatment of cells with ribavirin alone could also induce ISRE activation, but to a lesser extent; however, when cells were cotreated with ribavirin and beta interferon, ribavirin did not augment the interferon-induced ISRE activation.
- Published
- 2015
39. Inhibition of Enterovirus 71 by Adenosine Analog NITD008
- Author
-
Si Qing Liu, Sylvie Alonso, Huimin Yeo, Han-Qing Ye, Bao Di Shang, Cheng Lin Deng, Peng Gong, Bo Zhang, and Pei Yong Shi
- Subjects
Viral Plaque Assay ,Adenosine ,Combination therapy ,viruses ,Immunology ,Drug resistance ,Virus Replication ,Microbiology ,Antiviral Agents ,Mice ,Virology ,Vaccines and Antiviral Agents ,Chlorocebus aethiops ,Drug Resistance, Viral ,Enterovirus 71 ,medicine ,Enterovirus Infections ,Animals ,Vero Cells ,biology ,Viral encephalitis ,Viral Load ,biology.organism_classification ,medicine.disease ,Resistance mutation ,Enterovirus A, Human ,Viral replication ,Insect Science ,Mutation ,Viral load - Abstract
Enterovirus 71 (EV71) is a major viral pathogen in China and Southeast Asia. There is no clinically approved vaccine or antiviral therapy for EV71 infection. NITD008, an adenosine analog, is an inhibitor of flavivirus that blocks viral RNA synthesis. Here we report that NITD008 has potent antiviral activity against EV71. In cell culture, the compound inhibits EV71 at a 50% effective concentration of 0.67 μM and a 50% cytotoxic concentration of 119.97 μM. When administered at 5 mg/kg in an EV71 mouse model, the compound reduced viral loads in various organs and completely prevented clinical symptoms and death. To study the antiviral mechanism and drug resistance, we selected escape mutant viruses by culturing EV71 with increasing concentrations of NITD008. Resistance mutations were reproducibly mapped to the viral 3A and 3D polymerase regions. Resistance analysis with recombinant viruses demonstrated that either a 3A or a 3D mutation alone could lead to resistance to NITD008. A combination of both 3A and 3D mutations conferred higher resistance, suggesting a collaborative interplay between the 3A and 3D proteins during viral replication. The resistance results underline the importance of combination therapy required for EV71 treatment. IMPORTANCE Human enterovirus 71 (EV71) has emerged as a major cause of viral encephalitis in children worldwide, especially in the Asia-Pacific region. Vaccines and antivirals are urgently needed to prevent and treat EV71 infections. In this study, we report the in vitro and in vivo efficacy of NITD008 (an adenosine analog) as an inhibitor of EV71. The efficacy results validated the potential of nucleoside analogs as antiviral drugs for EV71 infections. Mechanistically, we showed that mutations in the viral 3A and 3D polymerases alone or in combination could confer resistance to NITD008. The resistance results suggest an intrinsic interaction between viral proteins 3A and 3D during replication, as well as the importance of combination therapy for the treatment of EV71 infections.
- Published
- 2014
40. High-Throughput Assays Using a Luciferase-Expressing Replicon, Virus-Like Particles, and Full-Length Virus for West Nile Virus Drug Discovery
- Author
-
David M. Ferguson, Francesc Puig-Basagoiti, Pei Yong Shi, Tia S. Deas, Ping Ren, and Mark Tilgner
- Subjects
Pharmacology ,viruses ,Viral translation ,Drug Evaluation, Preclinical ,Biology ,Virus Replication ,biology.organism_classification ,Antiviral Agents ,Virology ,Molecular biology ,Virus ,Flavivirus ,Infectious Diseases ,Viral replication ,Virus-like particle ,Viral entry ,Virion assembly ,Biological Assay ,Replicon ,Pharmacology (medical) ,Luciferases ,West Nile virus - Abstract
Many flaviviruses cause significant human disease worldwide. The development of flavivirus chemotherapy requires reliable high-throughput screening (HTS) assays. Although genetic systems have been developed for many flaviviruses, their usage in antiviral HTS assays has not been well explored. Here we compare three cell-based HTS assays for West Nile virus (WNV) drug discovery: (i) an assay that uses a cell line harboring a persistently replicating subgenomic replicon (containing a deletion of viral structural genes), (ii) an assay that uses packaged virus-like particles containing replicon RNA, and (iii) an assay that uses a full-length reporting virus. A Renilla luciferase gene was engineered into the replicon or into the full-length viral genome to monitor viral replication. Potential inhibitors could be identified through suppression of luciferase signals upon compound incubation. The antiviral assays were optimized in a 96-well format, validated with known WNV inhibitors, and proved useful in identifying a new inhibitor(s) through HTS of a compound library. In addition, because each assay encompasses multiple but discrete steps of the viral life cycle, the three systems could potentially be used to discriminate the mode of action of any inhibitor among viral entry (detected by assays ii and iii but not by assay i), replication (including viral translation and RNA synthesis; detected by assays i to iii), and virion assembly (detected by assay iii but not by assays i and ii). The approaches described in this study should be applicable to the development of cell-based assays for other flaviviruses.
- Published
- 2005
41. Stimulation of Hepatitis C Virus (HCV) Nonstructural Protein 3 (NS3) Helicase Activity by the NS3 Protease Domain and by HCV RNA-Dependent RNA Polymerase
- Author
-
C. Cheng Kao, Ranjith Kumar, Guangxiang Luo, Chen Zhang, Fenghua Yuan, Zhaohui Cai, Young Chan Kim, and Pei Yong Shi
- Subjects
viruses ,Hepatitis C virus ,medicine.medical_treatment ,Immunology ,Viral Nonstructural Proteins ,Biology ,medicine.disease_cause ,Microbiology ,chemistry.chemical_compound ,Virology ,RNA polymerase ,medicine ,NS5B ,NS3 ,Protease ,Serine Endopeptidases ,virus diseases ,Helicase ,biochemical phenomena, metabolism, and nutrition ,RNA Helicase A ,Molecular biology ,Recombinant Proteins ,digestive system diseases ,Genome Replication and Regulation of Viral Gene Expression ,NS2-3 protease ,Spectrometry, Fluorescence ,chemistry ,Insect Science ,biology.protein ,RNA, Viral ,RNA Helicases - Abstract
Hepatitis C virus (HCV) nonstructural protein 3 (NS3) possesses multiple enzyme activities. The N-terminal one-third of NS3 primarily functions as a serine protease, while the remaining two-thirds of NS3 serve as a helicase and nucleoside triphosphatase. Whether the multiple enzyme activities of NS3 are functionally interdependent and/or modulated by other viral NS proteins remains unclear. We performed biochemical studies to examine the functional interdependence of the NS3 protease and helicase domains and the modulation of NS3 helicase by NS5B, an RNA-dependent RNA polymerase (RdRp). We found that the NS3 protease domain of the full-length NS3 (NS3FL) enhances the NS3 helicase activity. Additionally, HCV RdRp stimulates the NS3FL helicase activity by more than sevenfold. However, the helicase activity of the NS3 helicase domain was unaffected by HCV RdRp. Glutathione S -transferase pull-down as well as fluorescence anisotropy results revealed that the NS3 protease domain is required for specific NS3 and NS5B interaction. These findings suggest that HCV RdRp regulates the functions of NS3 during HCV replication. In contrast, NS3FL does not increase NS5B RdRp activity in vitro, which is contrary to a previously published report that the HCV NS3 enhances NS5B RdRp activity.
- Published
- 2005
42. Inhibition of Flavivirus Infections by Antisense Oligomers Specifically Suppressing Viral Translation and RNA Replication
- Author
-
Iwona Binduga-Gajewska, Ping Ren, Laura D. Kramer, Patrick L. Iversen, Elizabeth B. Kauffman, Mark Tilgner, David A. Stein, Hong M. Moulton, Tia S. Deas, and Pei Yong Shi
- Subjects
Models, Molecular ,Morpholines ,viruses ,Molecular Sequence Data ,Immunology ,Virus Replication ,Microbiology ,Virus ,Cell Line ,Flavivirus Infections ,Morpholinos ,Viral life cycle ,Cricetinae ,Virology ,Vaccines and Antiviral Agents ,Protein biosynthesis ,Animals ,3' Untranslated Regions ,Base Sequence ,biology ,Flavivirus ,Viral translation ,RNA ,Oligonucleotides, Antisense ,biology.organism_classification ,Molecular biology ,Genetic translation ,Viral replication ,Protein Biosynthesis ,Insect Science ,Nucleic Acid Conformation ,RNA, Viral ,5' Untranslated Regions - Abstract
RNA elements within flavivirus genomes are potential targets for antiviral therapy. A panel of phosphorodiamidate morpholino oligomers (PMOs), whose sequences are complementary to RNA elements located in the 5′- and 3′-termini of the West Nile (WN) virus genome, were designed to anneal to important cis -acting elements and potentially to inhibit WN infection. A novel Arg-rich peptide was conjugated to each PMO for efficient cellular delivery. These PMOs exhibited various degrees of antiviral activity upon incubation with a WN virus luciferase-replicon-containing cell line. Among them, PMOs targeting the 5′-terminal 20 nucleotides (5′End) or targeting the 3′-terminal element involved in a potential genome cyclizing interaction (3′CSI) exhibited the greatest potency. When cells infected with an epidemic strain of WN virus were treated with the 5′End or 3′CSI PMO, virus titers were reduced by approximately 5 to 6 logs at a 5 μM concentration without apparent cytotoxicity. The 3′CSI PMO also inhibited mosquito-borne flaviviruses other than WN virus, and the antiviral potency correlated with the conservation of the targeted 3′CSI sequences of specific viruses. Mode-of-action analyses showed that the 5′End and 3′CSI PMOs suppressed viral infection through two distinct mechanisms. The 5′End PMO inhibited viral translation, whereas the 3′CSI PMO did not significantly affect viral translation but suppressed RNA replication. The results suggest that antisense PMO-mediated blocking of cis -acting elements of flavivirus genomes can potentially be developed into an anti-flavivirus therapy. In addition, we report that although a full-length WN virus containing a luciferase reporter (engineered at the 3′ untranslated region of the genome) is not stable, an early passage of this reporting virus can be used to screen for inhibitors against any step of the virus life cycle.
- Published
- 2005
43. Inhibition of Interferon Signaling by the New York 99 Strain and Kunjin Subtype of West Nile Virus Involves Blockage of STAT1 and STAT2 Activation by Nonstructural Proteins
- Author
-
Alexander A. Khromykh, Vladislav V. Mokhonov, Xiang Ju Wang, Wen Jun Liu, Richard E. Randall, and Pei Yong Shi
- Subjects
viruses ,Immunology ,Viral Nonstructural Proteins ,Microbiology ,Virus ,Cell Line ,Kunjin virus ,Interferon ,Virology ,Chlorocebus aethiops ,medicine ,Animals ,Humans ,Vero Cells ,NS3 ,biology ,STAT2 Transcription Factor ,biology.organism_classification ,Molecular biology ,Virus-Cell Interactions ,DNA-Binding Proteins ,Flavivirus ,STAT1 Transcription Factor ,Gene Expression Regulation ,Insect Science ,Trans-Activators ,Vero cell ,Phosphorylation ,Interferons ,Signal transduction ,West Nile virus ,Signal Transduction ,medicine.drug - Abstract
The interferon (IFN) response is the first line of defense against viral infections, and the majority of viruses have developed different strategies to counteract IFN responses in order to ensure their survival in an infected host. In this study, the abilities to inhibit IFN signaling of two closely related West Nile viruses, the New York 99 strain (NY99) and Kunjin virus (KUN), strain MRM61C, were analyzed using reporter plasmid assays, as well as immunofluorescence and Western blot analyses. We have demonstrated that infections with both NY99 and KUN, as well as transient or stable transfections with their replicon RNAs, inhibited the signaling of both alpha/beta IFN (IFN-α/β) and gamma IFN (IFN-γ) by blocking the phosphorylation of STAT1 and its translocation to the nucleus. In addition, the phosphorylation of STAT2 and its translocation to the nucleus were also blocked by KUN, NY99, and their replicons in response to treatment with IFN-α. IFN-α signaling and STAT2 translocation to the nucleus was inhibited when the KUN nonstructural proteins NS2A, NS2B, NS3, NS4A, and NS4B, but not NS1 and NS5, were expressed individually from the pcDNA3 vector. The results clearly demonstrate that both NY99 and KUN inhibit IFN signaling by preventing STAT1 and STAT2 phosphorylation and identify nonstructural proteins responsible for this inhibition.
- Published
- 2005
44. The Host Response to West Nile Virus Infection Limits Viral Spread through the Activation of the Interferon Regulatory Factor 3 Pathway
- Author
-
Maria W. Smith, Michael Gale, Pei Yong Shi, Brenda L. Fredericksen, and Michael G. Katze
- Subjects
viruses ,Immunology ,Viral Plaque Assay ,Biology ,Virus Replication ,Antiviral Agents ,Microbiology ,Virus ,Cell Line ,Mice ,Immunity ,Interferon ,Virology ,Chlorocebus aethiops ,medicine ,Animals ,Humans ,Vero Cells ,Gene ,Oligonucleotide Array Sequence Analysis ,Proteins ,Interferon-beta ,biology.organism_classification ,Immunity, Innate ,DNA-Binding Proteins ,Flavivirus ,Viral replication ,Insect Science ,Vero cell ,Pathogenesis and Immunity ,Interferon Regulatory Factor-3 ,West Nile virus ,HeLa Cells ,Transcription Factors ,Interferon regulatory factors ,medicine.drug - Abstract
Recent outbreaks of West Nile Virus (WNV) have been associated with an increase in morbidity and mortality in humans, birds, and many other species. We have initiated studies to define the molecular mechanisms by which a recent pathogenic isolate of WNV evades the host cell innate antiviral response. Biochemical and microarray analyses demonstrated that WNV induced the expression of beta interferon (IFN-β) and several IFN-stimulated genes late in infection of cultured human cells. The late expression of these antiviral genes was due to the delayed activation of the transcription factor IFN regulatory factor 3 (IRF-3). Despite this host response, WNV was still able to replicate efficiently. The effect of the IRF-3 pathway on WNV replication was assessed by examining virus replication and spread in cultures of wild-type or IRF-3-null mouse embryo fibroblasts. The absence of IRF-3 was marked by a significant increase in plaque size and a sustained production of infectious particles. Although the activation of the IRF-3 pathway was not sufficient to block virus replication, our results suggest that IRF-3 target genes function to constrain WNV infection and limit cell-to-cell virus spread.
- Published
- 2004
45. Tetracycline-Inducible Packaging Cell Line for Production of Flavivirus Replicon Particles
- Author
-
Richard Linedale, Michael Jacobs, Itaru Anraku, Andreas Suhrbier, Xiang Ju Wang, Wen Jun Liu, Alexander A. Khromykh, Pei Yong Shi, Thuy T. Le, Andrew D. Davidson, and Tracey J. Harvey
- Subjects
viruses ,Immunology ,Dengue virus ,Biology ,medicine.disease_cause ,complex mixtures ,Microbiology ,Virus ,Cell Line ,Mice ,Kunjin virus ,Cricetinae ,Virology ,Chlorocebus aethiops ,Vaccines and Antiviral Agents ,medicine ,Animals ,Replicon ,Vero Cells ,Flavivirus ,Virus Assembly ,Virion ,virus diseases ,RNA ,Dengue Virus ,Tetracycline ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,Molecular biology ,Insect Science ,Vero cell ,RNA transfection ,West Nile virus - Abstract
We have previously developed replicon vectors derived from the Australian flavivirus Kunjin that have a unique noncytopathic nature and have been shown to direct prolonged high-level expression of encoded heterologous genes in vitro and in vivo and to induce strong and long-lasting immune responses to encoded immunogens in mice. To facilitate further applications of these vectors in the form of virus-like particles (VLPs), we have now generated a stable BHK packaging cell line, tetKUNCprME, carrying a Kunjin structural gene cassette under the control of a tetracycline-inducible promoter. Withdrawal of tetracycline from the medium resulted in production of Kunjin structural proteins that were capable of packaging transfected and self-amplified Kunjin replicon RNA into the secreted VLPs at titers of up to 1.6 × 10 9 VLPs per ml. Furthermore, secreted KUN replicon VLPs from tetKUNCprME cells could be harvested continuously for as long as 10 days after RNA transfection, producing a total yield of more than 10 10 VLPs per 10 6 transfected cells. Passaging of VLPs on Vero cells or intracerebral injection into 2- to 4-day-old suckling mice illustrated the complete absence of any infectious Kunjin virus. tetKUNCprME cells were also capable of packaging replicon RNA from closely and distantly related flaviviruses, West Nile virus and dengue virus type 2, respectively. The utility of high-titer KUN replicon VLPs was demonstrated by showing increasing CD8 + -T-cell responses to encoded foreign protein with increasing doses of KUN VLPs. A single dose of 2.5 × 10 7 VLPs carrying the human respiratory syncytial virus M2 gene induced 1,400 CD8 T cells per 10 6 splenocytes in an ex vivo gamma interferon enzyme-linked immunospot assay. The packaging cell line thus represents a significant advance in the development of the noncytopathic Kunjin virus replicon-based gene expression system and may be widely applicable to the basic studies of flavivirus RNA packaging and virus assembly as well as to the development of gene expression systems based on replicons from different flaviviruses.
- Published
- 2004
46. Potential High-Throughput Assay for Screening Inhibitors of West Nile Virus Replication
- Author
-
Mark Tilgner, Michael K. Lo, and Pei Yong Shi
- Subjects
viruses ,Kanamycin kinase ,Immunology ,Drug Evaluation, Preclinical ,Biology ,Virus Replication ,Antiviral Agents ,Microbiology ,Cell Line ,Cricetinae ,Virology ,Vaccines and Antiviral Agents ,Animals ,Replicon ,Luciferases ,DNA Primers ,Reporter gene ,Base Sequence ,Kanamycin Kinase ,Reverse Transcriptase Polymerase Chain Reaction ,Drug discovery ,virus diseases ,RNA ,Transfection ,nervous system diseases ,Viral replication ,Cell culture ,Insect Science ,West Nile virus - Abstract
Prevention and treatment of infection by West Nile virus (WNV) and other flaviviruses are public health priorities. We describe a reporting cell line that can be used for high-throughput screening of inhibitors against all targets involved in WNV replication. Dual reporter genes, encoding Renilla luciferase (Rluc) and neomycin phosphotransferase (Neo), were engineered into a WNV subgenomic replicon, resulting in Rluc/NeoRep. Geneticin selection of BHK-21 cells transfected with Rluc/NeoRep yielded a stable cell line that contains persistently replicating replicons. Incubation of the reporting cells with known WNV inhibitors decreased Rluc activity, as well as the replicon RNA level. The efficacies of the inhibitors, as measured by the depression of Rluc activity in the reporting cells, are comparable to those derived from authentic viral infection assays. Therefore, the WNV reporting cell line can be used as a high-throughput assay for anti-WNV drug discovery. A similar approach should be applicable to development of genetics-based antiviral assays for other flaviviruses.
- Published
- 2003
47. Infectious cDNA Clone of the Epidemic West Nile Virus from New York City
- Author
-
Michael K. Lo, Pei Yong Shi, Kim A. Kent, Mark Tilgner, and Kristen A. Bernard
- Subjects
DNA, Complementary ,viruses ,Immunology ,Clone (cell biology) ,Replication ,Virulence ,Biology ,Microbiology ,Virus ,Disease Outbreaks ,Mice ,Plasmid ,Virology ,Complementary DNA ,Chlorocebus aethiops ,Animals ,Humans ,Cloning, Molecular ,Vero Cells ,Infectivity ,Reverse Transcriptase Polymerase Chain Reaction ,RNA ,Insect Science ,DNA, Viral ,Vero cell ,RNA, Viral ,New York City ,West Nile virus ,West Nile Fever - Abstract
We report the first full-length infectious clone of the current epidemic, lineage I, strain of West Nile virus (WNV). The full-length cDNA was constructed from reverse transcription-PCR products of viral RNA from an isolate collected during the year 2000 outbreak in New York City. It was cloned into plasmid pBR322 under the control of a T7 promoter and stably amplified in Escherichia coli HB101. RNA transcribed from the full-length cDNA clone was highly infectious upon transfection into BHK-21 cells, resulting in progeny virus with titers of 1 × 10 9 to 5 × 10 9 PFU/ml. The cDNA clone was engineered to contain three silent nucleotide changes to create a Sty I site (C to A and A to G at nucleotides [nt] 8859 and 8862, respectively) and to knock out an Eco RI site (A to G at nt 8880). These genetic markers were retained in the recovered progeny virus. Deletion of the 3′-terminal 199 nt of the cDNA transcript abolished the infectivity of the RNA. The plaque morphology, in vitro growth characteristics in mammalian and insect cells, and virulence in adult mice were indistinguishable for the parental and recombinant viruses. The stable infectious cDNA clone of the epidemic lineage I strain will provide a valuable experimental system to study the pathogenesis and replication of WNV.
- Published
- 2002
48. High-Throughput Detection of West Nile Virus RNA
- Author
-
Kristen A. Bernard, Pei Yong Shi, Laura D. Kramer, Andy Felton, Jennifer H. Tai, Gregory D. Ebel, Ping Ren, Alan P. Dupuis, Joseph G. Maffei, Elizabeth B. Kauffman, Kiet A. Ngo, Susan A. Jones, and David Nicholas
- Subjects
Microbiology (medical) ,Time Factors ,Bird Diseases ,Reverse Transcriptase Polymerase Chain Reaction ,RNA ,Robotics ,Biology ,biology.organism_classification ,Sensitivity and Specificity ,Virology ,Reverse transcriptase ,Virus ,Birds ,Flavivirus ,Culicidae ,Real-time polymerase chain reaction ,Nucleic acid ,Animals ,RNA, Viral ,Reagent Kits, Diagnostic ,RNA extraction ,West Nile virus ,Nested polymerase chain reaction ,West Nile Fever - Abstract
The recent outbreaks of West Nile virus (WNV) in the northeastern United States and other regions of the world have made it essential to develop an efficient protocol for surveillance of WNV. In the present report, we describe a high-throughput procedure that combines automated RNA extraction, amplification, and detection of WNV RNA. The procedure analyzed 96 samples in approximately 4.5 h. A robotic system, the ABI Prism 6700 Automated Nucleic Acid workstation, extracted RNA and set up reactions for real-time reverse transcription (RT)-PCR in a 96-well format. The robot extracted RNA with a recovery as efficient as that of a commercial RNA extraction kit. A real-time RT-PCR assay was used to detect and quantitate WNV RNA. Using in vitro transcribed RNA, we estimated the detection limit of the real-time RT-PCR to be approximately 40 copies of RNA. A standard RT-PCR assay was optimized to a sensitivity similar to that of the real-time RT-PCR. The standard assay can be reliably used to test a small number of samples or to confirm previous test results. Using internal primers in a nested RT-PCR, we increased the sensitivity by approximately 10-fold compared to that of the standard RT-PCR. The results of the study demonstrated for the first time that the use of an automated system for the purpose of large-scale viral RNA surveillance dramatically increased the speed and efficiency of sample throughput for diagnosis.
- Published
- 2001
49. A Chimeric Dengue Virus Vaccine using Japanese Encephalitis Virus Vaccine Strain SA14-14-2 as Backbone Is Immunogenic and Protective against Either Parental Virus in Mice and Nonhuman Primates
- Author
-
Zhong-Yu Liu, Yong-Qiang Deng, Shun-Ya Zhu, Yu-Hua Li, Xiaofeng Li, Pei Yong Shi, Hong-Jiang Wang, Huiqiang Yang, Tao Jiang, E-De Qin, Jie Ma, Yongxin Yu, Cheng-Feng Qin, Xue-Dong Yu, Shihua Li, Hui Zhao, Yu Zhang, and Qing Ye
- Subjects
viruses ,Immunology ,Cross immunity ,Dengue Vaccines ,Dengue virus ,medicine.disease_cause ,Antibodies, Viral ,Microbiology ,Virus ,Dengue fever ,Dengue ,Mice ,Viral Envelope Proteins ,Virology ,Vaccines and Antiviral Agents ,medicine ,Animals ,Humans ,Antibody-dependent enhancement ,Dengue vaccine ,Encephalitis Virus, Japanese ,Mice, Inbred BALB C ,Attenuated vaccine ,biology ,Dengue Virus ,biology.organism_classification ,medicine.disease ,Macaca mulatta ,Flavivirus ,Insect Science ,Female ,Immunization - Abstract
The development of a safe and efficient dengue vaccine represents a global challenge in public health. Chimeric dengue viruses (DENV) based on an attenuated flavivirus have been well developed as vaccine candidates by using reverse genetics. In this study, based on the full-length infectious cDNA clone of the well-known Japanese encephalitis virus live vaccine strain SA14-14-2 as a backbone, a novel chimeric dengue virus (named ChinDENV) was rationally designed and constructed by replacement with the premembrane and envelope genes of dengue 2 virus. The recovered chimeric virus showed growth and plaque properties similar to those of the parental DENV in mammalian and mosquito cells. ChinDENV was highly attenuated in mice, and no viremia was induced in rhesus monkeys upon subcutaneous inoculation. ChinDENV retained its genetic stability and attenuation phenotype after serial 15 passages in cultured cells. A single immunization with various doses of ChinDENV elicited strong neutralizing antibodies in a dose-dependent manner. When vaccinated monkeys were challenged with wild-type DENV, all animals except one that received the lower dose were protected against the development of viremia. Furthermore, immunization with ChinDENV conferred efficient cross protection against lethal JEV challenge in mice in association with robust cellular immunity induced by the replicating nonstructural proteins. Taken together, the results of this preclinical study well demonstrate the great potential of ChinDENV for further development as a dengue vaccine candidate, and this kind of chimeric flavivirus based on JE vaccine virus represents a powerful tool to deliver foreign antigens.
- Published
- 2013
50. Crystal Structure of Enterovirus 71 RNA-Dependent RNA Polymerase Complexed with Its Protein Primer VPg: Implication for a trans Mechanism of VPg Uridylylation
- Author
-
Zhiyong Lou, Cheng Chen, Honggang Zhou, Pei Yong Shi, Bo Zhang, Chao Shan, Zihe Rao, Cheng Yang, Yuna Sun, Peng Xu, and Yaxin Wang
- Subjects
Picornavirus ,viruses ,Immunology ,Mutant ,RNA-dependent RNA polymerase ,Context (language use) ,Crystallography, X-Ray ,Microbiology ,chemistry.chemical_compound ,Viral Proteins ,Virology ,RNA polymerase ,Chlorocebus aethiops ,Animals ,Binding site ,Protein Structure, Quaternary ,Vero Cells ,chemistry.chemical_classification ,biology ,Structure and Assembly ,biology.organism_classification ,RNA-Dependent RNA Polymerase ,Molecular biology ,Amino acid ,Enterovirus A, Human ,chemistry ,Biochemistry ,Insect Science ,Mutagenesis, Site-Directed ,Tyrosine ,Mutant Proteins ,Primer (molecular biology) ,Uridine Monophosphate ,Protein Binding - Abstract
Picornavirus RNA replication is initiated by VPg uridylylation, during which the hydroxyl group of the third tyrosine residue of the virally encoded protein VPg is covalently linked to two UMP molecules by RNA-dependent RNA polymerase (RdRp; also known as 3D pol ). We previously identified site 311, located at the base of the palm domain of the enterovirus 71 (EV71) RdRp, to be the site for EV71 VPg binding and uridylylation. Here we report the crystal structure of EV71 3D pol complexed with VPg. VPg was anchored at the bottom of the palm domain of the 3D pol molecule and exhibited an extended V-shape conformation. The corresponding interface on 3D pol was mainly formed by residues within site 311 and other residues in the palm and finger domains. Mutations of the amino acids of 3D pol involved in the VPg interaction ( 3D L319A, 3D D320A, and 3D Y335A) significantly disrupted VPg binding to 3D pol , resulting in defective VPg uridylylation. In contrast, these mutations did not affect the RNA elongation activity of 3D pol . In the context of viral genomic RNA, mutations that abolished VPg uridylylation activity were lethal for EV71 replication. Further in vitro analysis showed that the uridylylation activity was restored by mixing VPg-binding-defective and catalysis-defective mutants, indicating a trans mechanism for EV71 VPg uridylylation. Our results, together with previous results of other studies, demonstrate that different picornaviruses use distinct binding sites for VPg uridylylation.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.